{"content":"<li class=\"n-box-item date-title\" data-end=\"1529121599\" data-start=\"1529035200\" data-txt=\"Monday, December 23, 2019\">Friday, June 15, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3364426\" data-ts=\"1529098663\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADT\" target=\"_blank\">ADT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364426-after-hours-gainers-losers-06-15-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (06/15/2018)</a></h4><ul>     <li><b>Top gainers:</b>&nbsp;<a href='https://seekingalpha.com/symbol/ADT' title='The ADT Corporation'>ADT</a>&nbsp;<font color='green'>+3.1%</font>. <a href='https://seekingalpha.com/symbol/TDW' title='Tidewater, Inc.'>TDW</a>&nbsp;<font color='green'>+2.6%</font>. <a href='https://seekingalpha.com/symbol/BSBR' title='Banco Santander &#40;Brasil&#41; S.A.'>BSBR</a> <font color='green'>+1.8%</font>. <a href='https://seekingalpha.com/symbol/SOGO' title='Sogou'>SOGO</a>&nbsp;<font color='green'>+1.8%</font>. <a href='https://seekingalpha.com/symbol/TUP' title='Tupperware Brands Corporation'>TUP</a> <font color='green'>+1.6%</font>.</li>     <li><strong>Top Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/ELP' title='Companhia Paranaense de Energia &#40;COPEL&#41;'>ELP</a> <font color='red'>-1.5%</font>. <a href='https://seekingalpha.com/symbol/LOMA' title='Loma Negra Compania Industrial Argentina Sociedad  ADS'>LOMA</a>&nbsp;<font color='red'>-1.4%</font>.&nbsp;&nbsp;<a href='https://seekingalpha.com/symbol/I' title='Intelsat SA'>I</a>&nbsp;<font color='red'>-1.3%.&nbsp;</font><a href='https://seekingalpha.com/symbol/ITUB' title='Itau Unibanco Holding S.A.'>ITUB</a>&nbsp;<font color='red'>-1.1%</font>. <a href='https://seekingalpha.com/symbol/BCH' title='Banco de Chile'>BCH</a>&nbsp;<font color='red'>-1.1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364426\" data-linked=\"After Hours Gainers / Losers (06/15/2018)\" data-tweet=\"$ADT $ADT $TDW - After Hours Gainers / Losers (06/15/2018) https://seekingalpha.com/news/3364426-after-hours-gainers-losers-06-15-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3364426-after-hours-gainers-losers-06-15-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364425\" data-ts=\"1529097854\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PVAC\" target=\"_blank\">PVAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364425-pvacplus-3_7-fltplus-4_5-on-index-changes-nvda-to-s-and-p-100\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PVAC +3.7%, FLT +4.5% on index changes; NVDA to S&amp;P 100</a></h4><ul>   <li>Penn Virginia (NASDAQ:<a href='https://seekingalpha.com/symbol/PVAC' title='Penn Virginia Corporation'>PVAC</a>) is <font color='green'>up 3.7%</font> after hours on the news it's <a href=\"https://www.spice-indices.com/idpfiles/spice-assets/resources/public/documents/727360_time1fleet5nvid14.pdf?force_download=true\" target=\"_blank\">heading into the S&amp;P SmallCap 600</a>.</li>    <li>It will make the move prior to next Friday's open; it's replacing Analogic (NASDAQ:<a href='https://seekingalpha.com/symbol/ALOG' title='Analogic Corporation'>ALOG</a>), which is set to be acquired by Altaris Capital Partners around then.</li>    <li>Meanwhile, with AT&amp;T's <a href=\"https://seekingalpha.com/news/3364132-quick-moving-and-t-closes-time-warner-buyout-starting-new-era\" target=\"_blank\">$85B deal for Time Warner complete</a> and Time Warner (NYSE:<a href='https://seekingalpha.com/symbol/TWX' title='Time Warner Inc.'>TWX</a>) delisting, Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) will replace Time Warner in the S&amp;P 100, and FleetCor (NYSE:<a href='https://seekingalpha.com/symbol/FLT' title='FleetCor Technologies, Inc.'>FLT</a>) will replace Time Warner in the S&amp;P 500. Those moves are effective prior to Wednesday's open.</li>    <li><a href='https://seekingalpha.com/symbol/FLT' title='FleetCor Technologies, Inc.'>FLT</a> is <font color='green'>up 4.5%</font> after hours.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364425\" data-linked=\"PVAC +3.7%, FLT +4.5% on index changes; NVDA to S&amp;P 100\" data-tweet=\"$PVAC $PVAC $ALOG - PVAC +3.7%, FLT +4.5% on index changes; NVDA to S&amp;P 100 https://seekingalpha.com/news/3364425-pvacplus-3_7-fltplus-4_5-on-index-changes-nvda-to-s-and-p-100?source=tweet\" data-url=\"https://seekingalpha.com/news/3364425-pvacplus-3_7-fltplus-4_5-on-index-changes-nvda-to-s-and-p-100\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364400\" data-ts=\"1529094905\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENT\" target=\"_blank\">ENT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364400-global-eagleplus-6_6-northland-adds-praise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global Eagle +6.6% as Northland adds more praise</a></h4><ul>   <li>Global Eagle Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/ENT' title='Global Eagle Entertainment, Inc.'>ENT</a>) <font color='green'>rose 6.6%</font> after a new note from Northland highlights a turnaround in the \"top of the 2nd inning.\"</li>    <li>The company's in the \"early innings of a multi- year operational/financial comeback,\" analyst Paul Penney says. He has an Outperform rating with a $4.75 price target, implying a heavy 73% upside from today's closing price. (h/t Bloomberg)</li>    <li>A few weeks ago, Northland <a href=\"https://seekingalpha.com/news/3358558-global-eagle-northland-sees-split-gogo\" target=\"_blank\">praised Global Eagle</a> while noting its path departing from rival Gogo (NASDAQ:<a href='https://seekingalpha.com/symbol/GOGO' title='Gogo'>GOGO</a>), which it says is dealing with \"deep-rooted\" problems. <a href='https://seekingalpha.com/symbol/GOGO' title='Gogo'>GOGO</a> rose 1% today but is still <font color='red'>down 54%</font> YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364400\" data-linked=\"Global Eagle +6.6% as Northland adds more praise\" data-tweet=\"$ENT $ENT $GOGO - Global Eagle +6.6% as Northland adds more praise https://seekingalpha.com/news/3364400-global-eagleplus-6_6-northland-adds-praise?source=tweet\" data-url=\"https://seekingalpha.com/news/3364400-global-eagleplus-6_6-northland-adds-praise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364392\" data-ts=\"1529094247\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364392-ge-hits-lowest-in-two-months-fitch-cuts-rating\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE hits lowest in two months as Fitch cuts rating</a></h4><ul>     <li>General Electric (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='red'>-2.5%</font>) shares slumped in today's trade to a <a href=\"https://www.marketwatch.com/story/ges-stock-falls-3-straight-days-to-a-2-month-low-after-fitch-downgrade-2018-06-15\" target=\"_blank\">two-month low</a> after <a href=\"https://www.fitchratings.com/site/pr/10034658\" target=\"_blank\">Fitch Ratings downgrades its rating</a> a notch to A from A+ with a negative outlook.</li>     <li>Fitch expects GE's cash flow and earnings \"will continue to be constrained while it addresses underperformance in the Power business, evaluates its business portfolio, and carries out extensive restructuring actions to reduce its cost structure.\"</li>     <li>Fitch also cites the trend in GE's portfolio actions, the company's large net pension obligations, a meaningful reliance on commercial paper and factored receivables that contribute to elevated leverage, and a weaker balance sheet at GE Capital which increases the risk that future support may be needed from GE.</li>     <li>Standard &amp; Poor's also rates GE's credit at A, while Moody's rates it at A2.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364392\" data-linked=\"GE hits lowest in two months as Fitch cuts rating\" data-tweet=\"$GE - GE hits lowest in two months as Fitch cuts rating https://seekingalpha.com/news/3364392-ge-hits-lowest-in-two-months-fitch-cuts-rating?source=tweet\" data-url=\"https://seekingalpha.com/news/3364392-ge-hits-lowest-in-two-months-fitch-cuts-rating\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>147&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364375\" data-ts=\"1529092590\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOM\" target=\"_blank\">XOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364375-oil-prices-plunge-ahead-of-next-weeks-opec-meeting-energy-stocks-whacked\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil prices plunge ahead of next week&#39;s OPEC meeting; energy stocks whacked</a></h4><ul>     <li><a href=\"https://www.marketwatch.com/story/oil-under-pressure-on-expectations-of-opec-output-hike-2018-06-15\" target=\"_blank\">Oil prices settled sharply lower</a>, with Brent crude ending at a six-week low, as Saudi Arabia and Russia appear ready to raise production  at next week's OPEC meeting in Vienna.</li>     <li>August Brent settled <font color='red'>-3.3%</font> to $73.44/bbl, the lowest settlement since May 2 and capping a ~4% loss for the week, while July WTI finished <font color='red'>-2.7%</font> at $65.06/bbl, its lowest finish since June 6 as it lost 1% for the week.</li>     <li>Saudi Arabia is considering a production hike of 500K-1M bbl/day while Russia is looking at an increase of as much as 1.5M bbl/day, although the &ldquo;vast majority&rdquo; of OPEC producers are arguing against relaxing production curbs that have been in place for 18 months, says Helima Croft, head of commodity strategy at RBC Capital.</li>     <li>As a result, Croft thinks Saudi Arabia and the OPEC leadership likely will deliver a modest 500K bbl/day rise while signaling readiness to quickly fill serious supply gaps if needed; however, next week's meeting could prove so contentious that Saudi Arabia and Russia are left to act on their own.</li><li>In the stock market, energy companies are taking a beating: <a href='https://seekingalpha.com/symbol/XOM' title='Exxon Mobil Corporation'>XOM</a> <font color='red'>-1.4%</font>, <a href='https://seekingalpha.com/symbol/CVX' title='Chevron Corporation'>CVX</a> <font color='red'>-2%</font>, <a href='https://seekingalpha.com/symbol/CHK' title='Chesapeake Energy Corporation'>CHK</a> <font color='red'>-2.2%</font>, <a href='https://seekingalpha.com/symbol/BP' title='BP p.l.c.'>BP</a> <font color='red'>-2.8%</font>, <a href='https://seekingalpha.com/symbol/EOG' title='EOG Resources, Inc.'>EOG</a> <font color='red'>-2.9%</font>, <a href='https://seekingalpha.com/symbol/APA' title='Apache Corporation'>APA</a> <font color='red'>-3%</font>, <a href='https://seekingalpha.com/symbol/RDS.A' title='Royal Dutch Shell plc'>RDS.A</a> <font color='red'>-3.1%</font>, <a href='https://seekingalpha.com/symbol/DVN' title='Devon Energy Corporation'>DVN</a> <font color='red'>-3.6%</font>, <a href='https://seekingalpha.com/symbol/APC' title='Anadarko Petroleum Corporation'>APC</a> <font color='red'>-3.7%</font>, <a href='https://seekingalpha.com/symbol/PXD' title='Pioneer Natural Resources Company'>PXD</a> <font color='red'>-3.8%</font>, <a href='https://seekingalpha.com/symbol/COP' title='ConocoPhillips'>COP</a> <font color='red'>-4.2%</font>, <a href='https://seekingalpha.com/symbol/CLR' title='Continental Resources, Inc.'>CLR</a> <font color='red'>-5.5%</font>, <a href='https://seekingalpha.com/symbol/MRO' title='Marathon Oil Corporation'>MRO</a> <font color='red'>-5.6%</font>, <a href='https://seekingalpha.com/symbol/NBR' title='Nabors Industries Ltd.'>NBR</a> <font color='red'>-8%</font>, <a href='https://seekingalpha.com/symbol/WLL' title='Whiting Petroleum Corporation'>WLL</a> <font color='red'>-9.5%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/XOP' title='SPDR S&P Oil & Gas Exploration & Production ETF'>XOP</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/GUSH' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3x Shares ETF'>GUSH</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/IYE' title='iShares U.S. Energy ETF'>IYE</a>, <a href='https://seekingalpha.com/symbol/DUG' title='ProShares UltraShort Oil & Gas ETF'>DUG</a>, <a href='https://seekingalpha.com/symbol/DRIP' title='Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 3x Shares ETF'>DRIP</a>, <a href='https://seekingalpha.com/symbol/IEO' title='iShares U.S. Oil & Gas Exploration & Production ETF'>IEO</a>, <a href='https://seekingalpha.com/symbol/FIF' title='First Trust Energy Infrastructure Fund'>FIF</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/NDP' title='Tortoise Energy Independence Fund'>NDP</a>, <a href='https://seekingalpha.com/symbol/PXE' title='Invesco Dynamic Energy Exploration & Production Portfolio ETF'>PXE</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/RYE' title='Invesco S&P Equal Weight Energy ETF'>RYE</a>, <a href='https://seekingalpha.com/symbol/PXJ' title='Invesco Dynamic Oil & Gas Services Portfolio ETF'>PXJ</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/CRAK' title='VanEck Vectors Oil Refiners ETF'>CRAK</a>, <a href='https://seekingalpha.com/symbol/FXN' title='First Trust Energy AlphaDEX ETF'>FXN</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/DDG' title='ProShares Short Oil & Gas ETF'>DDG</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/NANR' title='SPDR S&P North American Natural Resources ETF'>NANR</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a>, <a href='https://seekingalpha.com/symbol/WTID' title='ProShares Daily 3x Inverse Crude ETN'>WTID</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a>, <a href='https://seekingalpha.com/symbol/USOU' title='United States 3x Oil Fund'>USOU</a>, <a href='https://seekingalpha.com/symbol/USOD' title='United States 3x Short Oil Fund ETF'>USOD</a>, <a href='https://seekingalpha.com/symbol/FTXN' title='First Trust Nasdaq Oil & Gas ETF'>FTXN</a>, <a href='https://seekingalpha.com/symbol/JHME' title='John Hancock Multifactor Energy ETF'>JHME</a>, <a href='https://seekingalpha.com/symbol/UBRT' title='Credit Suisse AxelaTrader 3x Long Brent Crude Oil ETN'>UBRT</a>, <a href='https://seekingalpha.com/symbol/ERYY' title='Direxion Daily Energy Bear 1x Shares ETF'>ERYY</a>, <a href='https://seekingalpha.com/symbol/DBRT' title='Credit Suisse AxelaTrader 3x Inverse Brent Crude Oil ETN'>DBRT</a>, <a href='https://seekingalpha.com/symbol/ERGF' title='iShares Edge MSCI Multifactor Energy ETF'>ERGF</a>, <a href='https://seekingalpha.com/symbol/OILD' title='ProShares UltraPro 3x Short Crude Oil ETF'>OILD</a>, <a href='https://seekingalpha.com/symbol/OILU' title='ProShares UltraPro 3x Crude Oil ETF'>OILU</a>, <a href='https://seekingalpha.com/symbol/USAI' title='American Energy Independence ETF'>USAI</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3364375\" data-linked=\"Oil prices plunge ahead of next week&#39;s OPEC meeting; energy stocks whacked\" data-tweet=\"$XOM $XOM $CVX - Oil prices plunge ahead of next week&#39;s OPEC meeting; energy stocks whacked https://seekingalpha.com/news/3364375-oil-prices-plunge-ahead-of-next-weeks-opec-meeting-energy-stocks-whacked?source=tweet\" data-url=\"https://seekingalpha.com/news/3364375-oil-prices-plunge-ahead-of-next-weeks-opec-meeting-energy-stocks-whacked\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>229&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364369\" data-ts=\"1529089853\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMI\" target=\"_blank\">BMI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364369-badger-meterplus-2_5-following-canaccord-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Badger Meter +2.5% following Canaccord upgrade</a></h4><ul>     <li>Badger Meter (<a href='https://seekingalpha.com/symbol/BMI' title='Badger Meter, Inc.'>BMI</a> <font color='green'>+2.5%</font>) moves higher after Canaccord Genuity <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/18/06/11886176/canaccord-badger-meter-has-positive-catalysts-balanced-\" target=\"_blank\">upgrades</a> shares to Hold from Sell with a $44 price target, raised from $40, saying BMI will continue to benefit from favorable demand for water/flow measurement and conservation technologies in the future.</li>     <li>While the firm likes BMI's technology and overall market positioning, it says the stock's valuation is at the higher end of historical ranges and well above peers.</li>     <li>Canaccord believes price increases will&nbsp;help offset the impact of rising commodity costs, and sees a more favorable domestic municipal market as well as continued momentum for oil, gas and industrial applications.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364369\" data-linked=\"Badger Meter +2.5% following Canaccord upgrade\" data-tweet=\"$BMI - Badger Meter +2.5% following Canaccord upgrade https://seekingalpha.com/news/3364369-badger-meterplus-2_5-following-canaccord-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3364369-badger-meterplus-2_5-following-canaccord-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364366\" data-ts=\"1529089110\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZEN\" target=\"_blank\">ZEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364366-zendesk-competitor-gets-26m-in-funding\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zendesk competitor gets $26M in funding</a></h4><ul><li>        Zendesk (NYSE:<a href='https://seekingalpha.com/symbol/ZEN' title='Zendesk, Inc.'>ZEN</a>) competitor Kustomer has raised <a href=\"https://techcrunch.com/2018/06/15/kustomer-gets-26m-to-take-on-zendesk-with-an-omnichannel-approach-to-customer-support/?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+Techcrunch+%28TechCrunch%29\" target=\"_blank\">$26M in Series B funding</a> led by early Zendesk investor Redpoint Ventures. Canaan Partners, Boldstart Ventures, and Social Leverage also participated.</li><li>                  Cisco (NASDAQ:<a href='https://seekingalpha.com/symbol/CSCO' title='Cisco Systems, Inc.'>CSCO</a>) Investments joined as a strategic investor.    </li><li>               The round brought Kustomer&rsquo;s total funding to $38.5M. &nbsp;&nbsp;&nbsp;</li><li>               Zendesk shares are&nbsp;<font color='red'>down 1%</font>&nbsp;to $58.81.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3364366\" data-linked=\"Zendesk competitor gets $26M in funding\" data-tweet=\"$ZEN $ZEN $CSCO - Zendesk competitor gets $26M in funding https://seekingalpha.com/news/3364366-zendesk-competitor-gets-26m-in-funding?source=tweet\" data-url=\"https://seekingalpha.com/news/3364366-zendesk-competitor-gets-26m-in-funding\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364365\" data-ts=\"1529089030\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLPS\" target=\"_blank\">CLPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364365-technology-top-5-gainers-losers-of-2_55-pm-06-15-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 2.55 PM (06/15/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/CLPS' title='CLPS, Inc'>CLPS</a> <font color='green'>+55%</font>. <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/OSS' title='One Stop Systems, Inc.'>OSS</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/NETE' title='Net Element International, Inc.'>NETE</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/ZUO' title='Zuora, Inc.'>ZUO</a> <font color='green'>+10%</font>.</li>     <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/VVPR' title='VivoPower International PLC'>VVPR</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/DQ' title='DAQO New Energy Corp.'>DQ</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/GRVY' title='GRAVITY Co., Ltd. - American depositary shares, each representing one'>GRVY</a> <font color='red'>-9%</font>. IFON <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/RFIL' title='RF Industries, Ltd.'>RFIL</a> <font color='red'>-9%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3364365\" data-linked=\"Technology - Top 5 Gainers / Losers as of 2.55 PM (06/15/2018)\" data-tweet=\"$CLPS $CLPS $LFIN - Technology - Top 5 Gainers / Losers as of 2.55 PM (06/15/2018) https://seekingalpha.com/news/3364365-technology-top-5-gainers-losers-of-2_55-pm-06-15-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3364365-technology-top-5-gainers-losers-of-2_55-pm-06-15-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364363\" data-ts=\"1529087704\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIG\" target=\"_blank\">RIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364363-transocean-to-retire-four-rigs-take-related-520m-q2-charge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Transocean to retire four rigs, take related $520M Q2 charge</a></h4><ul>     <li>Transocean (<a href='https://seekingalpha.com/symbol/RIG' title='Transocean Ltd.'>RIG</a> <font color='red'>-2.4%</font>) is lower after disclosing plans to <a href=\"https://www.sec.gov/Archives/edgar/data/1451505/000145150518000063/c505-20180614x8k.htm\" target=\"_blank\">retire four of its older rigs</a> and take a related $520M charge during Q2.</li>     <li>RIG says it continues to evaluate the long-term competitiveness of its fleet and may identify additional rigs as candidates for retirement.</li>     <li>Bernstein analyst Colin Davies <a href=\"https://www.barrons.com/articles/transocean-shows-scrappiness-by-retiring-old-rigs-1529071296?mod=hp_RTA\" target=\"_blank\">reiterates a Market Weight rating</a> on RIG, saying the company scrapped the rigs because they were not competitive in today's market as \"older rigs built before this decade's massive new build cycle are squeezed out and eventual scrappage is inevitable.\"</li>     <li>Many rig contractors have aging rigs on their books, including many \"ancient floaters built before 1998 with less book value exposure\" as well as those built during 1999-2005 that are old \"but still have much book value remaining,\" Davies says.</li>     <li>Along with RIG, Davies says Ensco (<a href='https://seekingalpha.com/symbol/ESV' title='Ensco PLC'>ESV</a> <font color='red'>-5.4%</font>) and Seadrill (<a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a> <font color='red'>-4.5%</font>) have the highest ownership of rigs at risk of scrapping but still with significant remaining book value.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364363\" data-linked=\"Transocean to retire four rigs, take related $520M Q2 charge\" data-tweet=\"$RIG $RIG $VAL - Transocean to retire four rigs, take related $520M Q2 charge https://seekingalpha.com/news/3364363-transocean-to-retire-four-rigs-take-related-520m-q2-charge?source=tweet\" data-url=\"https://seekingalpha.com/news/3364363-transocean-to-retire-four-rigs-take-related-520m-q2-charge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364362\" data-ts=\"1529087670\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GM\" target=\"_blank\">GM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364362-gm-jumps-on-report-of-cruise-listing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GM jumps on report of Cruise listing</a></h4><ul> <li>General Motors (<a href='https://seekingalpha.com/symbol/GM' title='General Motors Company'>GM</a> <font color='green'>+1.5%</font>) surges after Bloomberg reports that the company is considering listing shares of the Cruise Automation self-driving unit.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3364362\" data-linked=\"GM jumps on report of Cruise listing\" data-tweet=\"$GM - GM jumps on report of Cruise listing https://seekingalpha.com/news/3364362-gm-jumps-on-report-of-cruise-listing?source=tweet\" data-url=\"https://seekingalpha.com/news/3364362-gm-jumps-on-report-of-cruise-listing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364361\" data-ts=\"1529086864\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364361-boeing-assessing-possible-impact-of-tariffs-on-products\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boeing assessing possible impact of tariffs on its products</a></h4><ul>     <li>Boeing (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color='red'>-1.6%</font>) and Caterpillar (<a href='https://seekingalpha.com/symbol/CAT' title='Caterpillar Inc.'>CAT</a> <font color='red'>-2.1%</font>), among the companies potentially harmed the most by a U.S.-China tit-for-tat tariff fight, are today's two biggest decliners on the Dow Jones 30 index.</li>     <li>Boeing says it is <a href=\"https://www.reuters.com/article/us-boeing-tariffs/boeing-says-assessing-possible-impact-of-u-s-tariffs-on-products-idUSKBN1JB2FE\" target=\"_blank\">assessing the possible impacts</a> of tariffs on its supply chain and commercial business.</li>     <li>Separately, Boeing's head of commercial sales Ihssane Mounir says engine problems at Rolls-Royce have &ldquo;rattled&rdquo; the aviation industry but <a href=\"https://www.reuters.com/article/boeing-mounir-aircraft/boeing-sales-chief-says-rolls-setbacks-not-impacting-787-sales-idUSL8N1TH4X0\" target=\"_blank\">have not slowed sales of the 787 Dreamliner</a>.</li>     <li>&ldquo;I haven&rsquo;t seen any slowdown in sales right now,\" Mounir tells Reuters. \"These are growing and teething pains for any product.&rdquo;</li>     <li>Also, the Pentagon yesterday <a href=\"https://www.reuters.com/article/us-boeing-pentagon-pentagon/boeing-wins-1-5-billion-u-s-defense-contract-pentagon-idUSKBN1JA366\" target=\"_blank\">awarded Boeing a $1.5B contract</a> for upgrades of F/A-18A/B, C/D, E/F and EA-18G aircraft for the Navy and foreign military sales customers.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364361\" data-linked=\"Boeing assessing possible impact of tariffs on its products\" data-tweet=\"$BA $BA $CAT - Boeing assessing possible impact of tariffs on its products https://seekingalpha.com/news/3364361-boeing-assessing-possible-impact-of-tariffs-on-products?source=tweet\" data-url=\"https://seekingalpha.com/news/3364361-boeing-assessing-possible-impact-of-tariffs-on-products\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364360\" data-ts=\"1529085983\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBM\" target=\"_blank\">IBM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364360-stat-ibms-watson-health-scaling-back-hospital-contracts-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">STAT: IBM&#39;s Watson Health scaling back hospital contracts business</a></h4><ul><li>        IBM (NYSE:<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a>) Watson Health execs told employees this week that the division will scale back its business selling tools to help hospital manage contracts, according to <a href=\"https://www.statnews.com/2018/06/15/ibm-watson-health-scale-back-hospital-business/\" target=\"_blank\">STAT sources</a>.</li><li>               Watson Health had invested billions into winning contracts from hospitals that wanted to switch their payment systems to a patient outcome focus rather than volume of care.&nbsp;</li><li>               IBM shares are&nbsp;<font color='red'>down 0.4%</font>&nbsp;to $144.63.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3364333-ibm-acquires-mro-inventory-software-company\" target=\"_blank\">IBM acquires MRO inventory software company</a> (June 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3364360\" data-linked=\"STAT: IBM&#39;s Watson Health scaling back hospital contracts business\" data-tweet=\"$IBM - STAT: IBM&#39;s Watson Health scaling back hospital contracts business https://seekingalpha.com/news/3364360-stat-ibms-watson-health-scaling-back-hospital-contracts-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3364360-stat-ibms-watson-health-scaling-back-hospital-contracts-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364356\" data-ts=\"1529085791\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364356-retail-stocks-hitting-52-week-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Retail stocks hitting their 52-week high</a></h4><ul> <li>A number of retail stocks are having solid days to push to new 52-week highs. The list of gainers includes Lululemon (<a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a> <font color='green'>+2.2%</font>), The Container Store (<a href='https://seekingalpha.com/symbol/TCS' title='The Container Store Group, Inc.'>TCS</a> <font color='green'>+6.8%</font>), Canada Goose (<a href='https://seekingalpha.com/symbol/GOOS' title='Canada Goose Holdings'>GOOS</a> <font color='green'>+28.1%</font>), Costco (<a href='https://seekingalpha.com/symbol/COST' title='Costco Wholesale Corporation'>COST</a> <font color='green'>+0.9%</font>),  Wayfair (<a href='https://seekingalpha.com/symbol/W' title='Wayfair'>W</a> <font color='green'>+2.6%</font>), Domino's Pizza (<a href='https://seekingalpha.com/symbol/DPZ' title='Domino&#39;s Pizza, Inc.'>DPZ</a> <font color='green'>+0.9%</font>) and Texas Roadhouse (<a href='https://seekingalpha.com/symbol/TXRH' title='Texas Roadhouse, Inc.'>TXRH</a> <font color='green'>+1.8%</font>).</li> <li>The group of consumer-facing companies is the for the most part shielded from some of the tariff anxiety hitting the broad market.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3364356\" data-linked=\"Retail stocks hitting their 52-week high\" data-tweet=\"$LULU $LULU $TCS - Retail stocks hitting their 52-week high https://seekingalpha.com/news/3364356-retail-stocks-hitting-52-week-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3364356-retail-stocks-hitting-52-week-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364355\" data-ts=\"1529085666\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAK\" target=\"_blank\">BAK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364355-energy-materials-top-gainers-losers-of-2-00-pm-06-15-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 PM (06/15/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/BAK' title='Braskem S.A.'>BAK</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/SCHN' title='Schnitzer Steel Industries, Inc.'>SCHN</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MXC' title='Mexco Energy Corporation'>MXC</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/EGY' title='VAALCO Energy, Inc.'>EGY</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/ENSV' title='Enservco Corp.'>ENSV</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/NBR' title='Nabors Industries Ltd.'>NBR</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/SN' title='Sanchez Energy Corporation'>SN</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364355\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 PM (06/15/2018)\" data-tweet=\"$BAK $BAK $SCHN - Energy/Materials - Top Gainers / Losers as of 2:00 PM (06/15/2018) https://seekingalpha.com/news/3364355-energy-materials-top-gainers-losers-of-2-00-pm-06-15-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3364355-energy-materials-top-gainers-losers-of-2-00-pm-06-15-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364347\" data-ts=\"1529083002\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALDR\" target=\"_blank\">ALDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364347-tevas-pain-is-alders-gain-in-migraine-shares-up-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teva&#39;s pain is Alder&#39;s gain in migraine; shares up 15%</a></h4><ul><li>Alder Biopharma (<a href='https://seekingalpha.com/symbol/ALDR' title='Alder Biopharmaceuticals Inc.'>ALDR</a> <font color='green'>+14.8%</font>) is up on almost 40% higher volume as investors believe that Teva's exit from developing CGRP inhibitor fremenezumab for chronic cluster headache is a positive for Alder's CGRP inhibitor eptinezumab, in Phase 3 development for chronic and episodic migraine.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3364207-teva-bails-fremanezumab-chronic-cluster-headache-late-stage-study-shares-2-percent-premarket\" target=\"_blank\">Teva bails on fremanezumab for chronic cluster headache in late-stage study; shares down 2% premarket</a> (June 15)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3347991-alders-eptinezumab-shows-treatment-benefit-late-stage-migraine-study\" target=\"_blank\">Alder's eptinezumab shows treatment benefit in late-stage migraine study</a> (April 24)</li></ul><div class=\"tiny-share-widget\" data-id=\"3364347\" data-linked=\"Teva&#39;s pain is Alder&#39;s gain in migraine; shares up 15%\" data-tweet=\"$ALDR - Teva&#39;s pain is Alder&#39;s gain in migraine; shares up 15% https://seekingalpha.com/news/3364347-tevas-pain-is-alders-gain-in-migraine-shares-up-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3364347-tevas-pain-is-alders-gain-in-migraine-shares-up-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364340\" data-ts=\"1529082027\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TCI\" target=\"_blank\">TCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364340-financials-top-gainers-losers-of-1-00-pm-06-15-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top Gainers / Losers as of 1:00 PM (06/15/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/TCI' title='Transcontinental Realty Investors Inc.'>TCI</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/DNJR' title='Golden Bull Ltd'>DNJR</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/SIEB' title='Siebert Financial Corp.'>SIEB</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/PPDF' title='PPDAI Group Inc.'>PPDF</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/HCC' title='Warrior Met Coal'>HCC</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/NAVI' title='Navient Corp'>NAVI</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/CRF' title='Cornerstone Total Return Fund'>CRF</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364340\" data-linked=\"Financials - Top Gainers / Losers as of 1:00 PM (06/15/2018)\" data-tweet=\"$TCI $TCI $DNJR - Financials - Top Gainers / Losers as of 1:00 PM (06/15/2018) https://seekingalpha.com/news/3364340-financials-top-gainers-losers-of-1-00-pm-06-15-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3364340-financials-top-gainers-losers-of-1-00-pm-06-15-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364336\" data-ts=\"1529080586\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLPS\" target=\"_blank\">CLPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364336-midday-gainers-losers-06-15-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (06/15/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/CLPS' title='CLPS, Inc'>CLPS</a> <font color='green'>+34%</font>. <a href='https://seekingalpha.com/symbol/GOOS' title='Canada Goose Holdings'>GOOS</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/NDRA' title='Endra Life Sciences Inc'>NDRA</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/BAK' title='Braskem S.A.'>BAK</a> <font color='green'>+19%</font>. TPIV <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/VSTM' title='Verastem, Inc.'>VSTM</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/CFRX' title='ContraFect Corp.'>CFRX</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/NETE' title='Net Element International, Inc.'>NETE</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/TCI' title='Transcontinental Realty Investors Inc.'>TCI</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/NEWA' title='Newater Technology, Inc.'>NEWA</a> <font color='green'>+13%</font>.</li>     <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/ACHV' title='Achieve Life Sciences, Inc.'>ACHV</a> <font color='red'>-30%</font>. <a href='https://seekingalpha.com/symbol/CUR' title='Neuralstem, Inc.'>CUR</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/AFMD' title='Affimed Therapeutics'>AFMD</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/NFEC' title='NF Energy Saving Corp.'>NFEC</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/GBT' title='Global Blood Therapeutics'>GBT</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/CLWT' title='Euro Tech Holdings Company Limited'>CLWT</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/CYTX' title='Cytori Therapeutics Inc'>CYTX</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/HCC' title='Warrior Met Coal'>HCC</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/VVPR' title='VivoPower International PLC'>VVPR</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/NVIV' title='InVivo Therapeutics Holdings Corp'>NVIV</a> <font color='red'>-10%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3364336\" data-linked=\"Midday Gainers / Losers (06/15/2018)\" data-tweet=\"$CLPS $CLPS $GOOS - Midday Gainers / Losers (06/15/2018) https://seekingalpha.com/news/3364336-midday-gainers-losers-06-15-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3364336-midday-gainers-losers-06-15-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364333\" data-ts=\"1529080143\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBM\" target=\"_blank\">IBM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364333-ibm-acquires-mro-inventory-software-company\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IBM acquires MRO inventory software company</a></h4><ul><li>        IBM (NYSE:<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a>) <a href=\"https://seekingalpha.com/pr/17193533-ibm-acquires-oniqua-strengthens-leading-iot-capabilities-help-businesses-proactively-maintain\" target=\"_blank\">acquires</a> Oniqua Holdings for undisclosed terms.</li><li>               Oniqua Holdings makes Maintenance Repair and Operations &#40;MRO&#41; inventory optimization software for industrial use. IBM is acquiring the team and the tech.&nbsp;</li><li>               IBM says the acquisition expands its Asset Optimization Practice in helping clients streamline inventories and predict when parts and equipment might fail to avoid downtime.&nbsp;</li><li>               IBM shares are&nbsp;<font color='red'>down 0.5%</font>&nbsp;to $144.47. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3364333\" data-linked=\"IBM acquires MRO inventory software company\" data-tweet=\"$IBM - IBM acquires MRO inventory software company https://seekingalpha.com/news/3364333-ibm-acquires-mro-inventory-software-company?source=tweet\" data-url=\"https://seekingalpha.com/news/3364333-ibm-acquires-mro-inventory-software-company\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364332\" data-ts=\"1529080002\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/I\" target=\"_blank\">I</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364332-intelsat-demonstrating-8k-video-for-world-cup\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intelsat demonstrating 8K video for World Cup</a></h4><ul>   <li>Intelsat (<a href=\"http://seekingalpha.com/symbol/I\" target=\"_blank\">I</a> <font color='green'>+3.9%</font>) is partnering with Latin American broadcaster Globo to demonstrate <a href=\"https://seekingalpha.com/pr/17193230-intelsat-partners-globo-demonstrate-8k-video-transmission-world-cup\" target=\"_blank\">live 8K video transmissions</a> for this year's World Cup.</li>    <li>Starting today and running through July 15, the company will use Intelsat 14 (the newest emerging HD video neighborhood in Latin America) to display matches in 7680 x 4320 pixels at Rio de Janeiro&rsquo;s Museu de Amanh&atilde;.</li>    <li>That will require transmitting a 200 Mbps video stream from Moscow to Tokyo and then carrying it to Intelsat via a New York point of presence, then via terrestrial network to its Atlanta teleport for re-encoding and compression.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364332\" data-linked=\"Intelsat demonstrating 8K video for World Cup\" data-tweet=\"$I - Intelsat demonstrating 8K video for World Cup https://seekingalpha.com/news/3364332-intelsat-demonstrating-8k-video-for-world-cup?source=tweet\" data-url=\"https://seekingalpha.com/news/3364332-intelsat-demonstrating-8k-video-for-world-cup\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364327\" data-ts=\"1529079361\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNCE\" target=\"_blank\">VNCE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364327-vince-holding-up-7-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vince Holding up 7% post Q1 results</a></h4><ul><li>Vince Holding (<a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a> <font color='green'>+7.6%</font>) reported Q1 net sales of $54.5M (-6.1% Y/Y).&nbsp;Segment sales: Wholesale $28.5M (-19.5% Y/Y), sales decreased due to planned reduction in full-price wholesale partners, and Direct-to-customers $26M (+14.9% Y/Y).</li><li>Comparable sales grew by 12.3% due to an increase in transactions.</li><li>Q1 Overall margins: Gross<font color='green'> improved by 275 bps</font>&nbsp;to 46.8% and operating<font color='green'> recovered by 611 bps</font>&nbsp;to -8%.</li><li>SG&amp;A expenses decreased by 11.5% Y/Y to $29.9M, reflecting lower product development cost and the non-recurrence of investments made last year.</li><li>Net inventory was at $49.4M (+55% Y/Y) the increase is due to change in the timing of shipments to the off-price wholesale channel, growth of the replenishment program, and the reinstatement of summer collection.</li><li>Cash and cash equivalents of $5.2M and $50.6M in borrowings under debt agreements.</li><li>FY18 Outlook: Net sales $273-280M and operating income $3-6M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3364059-vince-reports-q1-results\" target=\"_blank\">Vince reports Q1 results</a> (June 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3364327\" data-linked=\"Vince Holding up 7% post Q1 results\" data-tweet=\"$VNCE - Vince Holding up 7% post Q1 results https://seekingalpha.com/news/3364327-vince-holding-up-7-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3364327-vince-holding-up-7-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364331\" data-ts=\"1529079343\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVLR\" target=\"_blank\">AVLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364331-avalara-starts-first-day-of-trade-up-46\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avalara starts first day of trade up 46%</a></h4><ul><li>           Avalara (NYSE:<a href='https://seekingalpha.com/symbol/AVLR' title='Avalara'>AVLR</a>) shares opened the first day of trading up nearly 46% from the $24 pricing. </li><li> The company sells automated tax compliance software for businesses and includes integrations with Oracle, Workday, and Stripe. </li><li> Competitors: CCH Incorporated (<a href='https://seekingalpha.com/symbol/WOLTF' title='Wolters Kluwer N.V.'>OTC:WOLTF</a>, <a href='https://seekingalpha.com/symbol/WTKWY' title='Wolters Kluwer N.V. ADR'>OTCPK:WTKWY</a>), ONESOURCE Indirect Tax (NYSE:<a href='https://seekingalpha.com/symbol/TRI' title='Thomson Reuters Corporation'>TRI</a>), Sovos and Vertex. &nbsp; </li><li> Other cloud-related companies getting a boost: Zuora (<a href='https://seekingalpha.com/symbol/ZUO' title='Zuora, Inc.'>ZUO</a> <font color='green'>+5.7%</font>), Dropbox (<a href='https://seekingalpha.com/symbol/DBX' title='Dropbox'>DBX</a> <font color='green'>+7.6%</font>), Carbon Black (<a href='https://seekingalpha.com/symbol/CBLK' title='Carbon Black'>CBLK</a> <font color='green'>+4.3%</font>), MongoDB (<a href='https://seekingalpha.com/symbol/MDB' title='MongoDB, Inc.'>MDB</a> <font color='green'>+0.9%</font>).&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3363741-avalara-preps-ipo\" target=\"_blank\">Avalara preps for IPO</a> (June 13)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3364123-avalara-prices-ipo-range-24-share\" target=\"_blank\">Avalara prices IPO above range, at $24/share</a> (June 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3364331\" data-linked=\"Avalara starts first day of trade up 46%\" data-tweet=\"$AVLR $AVLR $WOLTF - Avalara starts first day of trade up 46% https://seekingalpha.com/news/3364331-avalara-starts-first-day-of-trade-up-46?source=tweet\" data-url=\"https://seekingalpha.com/news/3364331-avalara-starts-first-day-of-trade-up-46\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364330\" data-ts=\"1529079106\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CISN\" target=\"_blank\">CISN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364330-cision-prices-secondary-offering-sharesminus-3_2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cision prices secondary offering; shares -3.2%</a></h4><ul>     <li>Cision (<a href='https://seekingalpha.com/symbol/CISN' title='Cision Ltd.'>CISN</a> <font color='red'>-3.3%</font>) today announced the pricing of an underwritten public offering of 12M ordinary shares by certain selling shareholders at a public offering price of $15.00/share.</li>     <li>Cision is not selling any ordinary shares in the offering and will not receive any proceeds from the offering by the selling shareholders.</li>     <li>The offering is expected to close on June 19, 2018, subject to customary closing conditions.</li><li><a href=\"https://seekingalpha.com/pr/17193073-cision-ltd-announces-pricing-secondary-offering\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3364330\" data-linked=\"Cision prices secondary offering; shares -3.2%\" data-tweet=\"$CISN - Cision prices secondary offering; shares -3.2% https://seekingalpha.com/news/3364330-cision-prices-secondary-offering-sharesminus-3_2?source=tweet\" data-url=\"https://seekingalpha.com/news/3364330-cision-prices-secondary-offering-sharesminus-3_2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364329\" data-ts=\"1529078921\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VALE\" target=\"_blank\">VALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364329-samarco-reportedly-near-settlement-brazil-prosecutors\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Samarco reportedly near settlement with Brazil prosecutors</a></h4><ul><li>Joint venture partners Vale (<a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color='red'>-3.7%</font>) and BHP Billiton (<a href='https://seekingalpha.com/symbol/BHP' title='BHP Billiton Limited'>BHP</a> <font color='red'>-3.9%</font>) are <a href=\"http://www.miningweekly.com/article/samarco-is-said-to-be-nearing-settlement-with-brazil-prosecutors-2018-06-15\" target=\"_blank\">close to signing a definitive settlement</a> with Brazilian prosecutors  that will clear the way to restart Samarco iron ore operations and debt talks to  begin, Bloomberg reports.</li><li>The partners have secured four court  extensions to negotiate the settlement of a multibillion-dollar claim  stemming from the fatal 2015 tailings dam disaster, but this time the group is on track to meet the deadline, which now stands at June 25, according to the report.</li><li>A settlement reportedly would allow talks with creditors to begin as Samarco starts to draft  its long-term business plan, although any restructuring deal would require a firm restart date; Vale&rsquo;s best case is a  limited restart in H1 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364329\" data-linked=\"Samarco reportedly near settlement with Brazil prosecutors\" data-tweet=\"$VALE $VALE $BHP - Samarco reportedly near settlement with Brazil prosecutors https://seekingalpha.com/news/3364329-samarco-reportedly-near-settlement-brazil-prosecutors?source=tweet\" data-url=\"https://seekingalpha.com/news/3364329-samarco-reportedly-near-settlement-brazil-prosecutors\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364326\" data-ts=\"1529078559\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEE\" target=\"_blank\">LEE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364326-lee-enterprises-cfo-mayo-resigns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lee Enterprises CFO Mayo resigns</a></h4><ul>   <li>Ronald Mayo is <a href=\"https://seekingalpha.com/pr/17193172-ronald-mayo-announces-plans-leave-lee-enterprises\" target=\"_blank\">resigning his posts</a> as VP, chief financial officer and treasurer of Lee Enterprises (<a href=\"http://seekingalpha.com/symbol/LEE\" target=\"_blank\">LEE</a> <font color='green'>+2.9%</font>).</li>    <li>He'll return to Denver for family considerations after dealing with a medical issue; he's been on leave since April.</li>    <li>&ldquo;Since joining Lee in 2015, I have been commuting between Davenport and Denver,\" Lee says. \"While I am fully recovered from my medical issue, the recent events made me realize the importance of living and working in the same city as my family.\"</li>    <li>Tim Millage will serve as acting principal financial and accounting officer.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364326\" data-linked=\"Lee Enterprises CFO Mayo resigns\" data-tweet=\"$LEE - Lee Enterprises CFO Mayo resigns https://seekingalpha.com/news/3364326-lee-enterprises-cfo-mayo-resigns?source=tweet\" data-url=\"https://seekingalpha.com/news/3364326-lee-enterprises-cfo-mayo-resigns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364325\" data-ts=\"1529078498\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOS\" target=\"_blank\">GOOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364325-consumer-top-gainers-losers-of-12-00-pm-06-15-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 PM (06/15/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GOOS' title='Canada Goose Holdings'>GOOS</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/PETZ' title='TDH Holdings, Inc.'>PETZ</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/FIZZ' title='National Beverage Corp.'>FIZZ</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ROX' title='Castle Brands Inc'>ROX</a> <font color='red'>-6%</font>. AOI <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364325\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 PM (06/15/2018)\" data-tweet=\"$GOOS $GOOS $VNCE - Consumer - Top Gainers / Losers as of 12:00 PM (06/15/2018) https://seekingalpha.com/news/3364325-consumer-top-gainers-losers-of-12-00-pm-06-15-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3364325-consumer-top-gainers-losers-of-12-00-pm-06-15-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364323\" data-ts=\"1529078258\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHKE\" target=\"_blank\">CHKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364323-cherokee-down-8-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cherokee down 8% post Q1 results</a></h4><ul><li>Cherokee (<a href='https://seekingalpha.com/symbol/CHKE' title='Cherokee Inc.'>CHKE</a> <font color='red'>-8%</font>)&nbsp;<a href=\"https://seekingalpha.com/filing/4067624\" target=\"_blank\">reports Q1</a> revenue decrease of 20.8% Y/Y to $5.4M.</li><li>S, G&amp;A expenses were&nbsp;$4.4M (-26.7% Y/Y), the Y/Y decrease is due to reduced spending for personnel along with lower professional fees and other operating expenses following the completion of the Hi-Tec consolidation.</li><li>Adj. EBITDA margin&nbsp;<font color='green'>increased 528 bps</font>&nbsp;to 18.5%, this improvement was due to the decrease in S, G&amp;A expenses.</li><li>Operating loss of $0.2M (-91.3% Y/Y) &amp; net loss of $2.7M (-18.2% Y/Y).</li><li>Cash &amp; equivalents of $2.5M and $49.1M of borrowings outstanding under its credit agreement.</li><li>The Company continues to face liquidity challenges with recurring operating losses and negative cash flows, it plans to address the Company&rsquo;s ability to continue as a going concern through further negotiations with its lender and with other potential sources of capital.</li><li><strong>2019 Outlook:</strong> Revenues of $25-27M; Adj. EBITDA of $8-10M; SG&amp;A of ~$17M, a reduction of $8.4M Y/Y.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3364048-cherokee-misses-0_11-beats-revenue\" target=\"_blank\">Cherokee misses by $0.11, beats on revenue</a> (June 14)</li></ul> &middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;<div class=\"tiny-share-widget\" data-id=\"3364323\" data-linked=\"Cherokee down 8% post Q1 results\" data-tweet=\"$CHKE $APEX - Cherokee down 8% post Q1 results https://seekingalpha.com/news/3364323-cherokee-down-8-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3364323-cherokee-down-8-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364324\" data-ts=\"1529078258\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NAV\" target=\"_blank\">NAV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364324-navistarplus-5-investors-bet-on-volkswagen-bid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Navistar +5% as investors bet on Volkswagen bid</a></h4><ul> <li>Navistar (NYSE:<a href='https://seekingalpha.com/symbol/NAV' title='Navistar International Corporation'>NAV</a>)&nbsp;is <font color='green'>up 5.45%</font> as investors seize on the the new hiring at Volkswagen Truck &amp; Bus as a sign that a full takeover of the company could be on the way. Jefferies has gone as far today as to say a deal is \"likely.\"</li> <li>Volkswagen Truck &amp; Bus, which is prepping for a potential IPO, already has 17% of Navistar's shares in its back pocket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3364213-navistar-watch-volkswagen-lurks\" target=\"_blank\">Navistar on watch as Volkswagen lurks</a> (June 15)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3364324\" data-linked=\"Navistar +5% as investors bet on Volkswagen bid\" data-tweet=\"$NAV - Navistar +5% as investors bet on Volkswagen bid https://seekingalpha.com/news/3364324-navistarplus-5-investors-bet-on-volkswagen-bid?source=tweet\" data-url=\"https://seekingalpha.com/news/3364324-navistarplus-5-investors-bet-on-volkswagen-bid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364317\" data-ts=\"1529077578\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLRN\" target=\"_blank\">XLRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364317-accelerons-luspatercept-continues-to-show-positive-effects-in-mid-stage-beta-thalassemia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acceleron&#39;s luspatercept continues to show positive effects in mid-stage beta-thalassemia studies</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17193215-acceleron-announces-updated-results-ongoing-phase-2-trials-luspatercept-beta-thalassemia-23rd\" target=\"_blank\">Updated results</a> from two Phase 2 clinical trials evaluating Acceleron Pharma's (<a href='https://seekingalpha.com/symbol/XLRN' title='Acceleron Pharma Inc.'>XLRN</a> <font color='red'>-1.3%</font>)&nbsp; luspatercept in &beta;-thalassemia patients showed a treatment benefit. The data were presented at the EHA Annual Meeting in Stockholm.</li><li>41% (n=13) of 32 transfusion-dependent patients treated with luspatercept experienced a reduction in red blood cell transfusion burden of at least 33% from baseline.</li><li>53% (n=16/30) on non-transfusion-dependent patients experienced at least a 1 gram/dL increase in hemoglobin from baseline.</li><li>Shares have been unable buck the market's selloff. A contributing factor may be bluebird bio's <a href=\"https://seekingalpha.com/news/3364224-bluebirds-lentiglobin-shows-significant-treatment-benefit-beta-thalassemia-patients-shares-1\" target=\"_blank\">mid-stage data</a> on gene therapy LentiGlobin in transfusion-dependent &beta;-thalassemia. Seven of eight treated patients maintained hemoglobin levels just below the normal range and have remained transfusion-free for as long as 15 months (follow-up is continuing).</li></ul><div class=\"tiny-share-widget\" data-id=\"3364317\" data-linked=\"Acceleron&#39;s luspatercept continues to show positive effects in mid-stage beta-thalassemia studies\" data-tweet=\"$XLRN - Acceleron&#39;s luspatercept continues to show positive effects in mid-stage beta-thalassemia studies https://seekingalpha.com/news/3364317-accelerons-luspatercept-continues-to-show-positive-effects-in-mid-stage-beta-thalassemia?source=tweet\" data-url=\"https://seekingalpha.com/news/3364317-accelerons-luspatercept-continues-to-show-positive-effects-in-mid-stage-beta-thalassemia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364316\" data-ts=\"1529076804\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MPO\" target=\"_blank\">MPO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364316-midstates-corrects-sandridge-statement-says-was-inaccurate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midstates corrects SandRidge statement it says was inaccurate</a></h4><ul>     <li>Midstates Petroleum (<a href='https://seekingalpha.com/symbol/MPO' title='Midstates Petroleum'>MPO</a> <font color='red'>-3.5%</font>) says a statement <a href=\"https://seekingalpha.com/news/3364283-sandridge-says-17-potential-buyers-including-icahn\" target=\"_blank\">issued earlier today</a> by SandRidge Energy (<a href='https://seekingalpha.com/symbol/SD' title='SandRidge Energy, Inc.'>SD</a> <font color='green'>+1.3%</font>) <a href=\"https://seekingalpha.com/pr/17193506-midstates-petroleum-corrects-sandridge-energy-s-inaccurate-statements\" target=\"_blank\">contained inaccuracies</a>; shares are halted.</li>     <li>\"While SandRidge has offered a non-disclosure agreement to Midstates, it would require Midstates to enter into a standstill, which is an unusual  requirement for a party that has made a public offer,\" MPO says.</li><li>Also, MPO says SD said it would \"not provide Midstates with internal forecasts that it is providing other process participants even if Midstates were to sign the NDA offered by SandRidge.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3364316\" data-linked=\"Midstates corrects SandRidge statement it says was inaccurate\" data-tweet=\"$MPO $AMPY $SD - Midstates corrects SandRidge statement it says was inaccurate https://seekingalpha.com/news/3364316-midstates-corrects-sandridge-statement-says-was-inaccurate?source=tweet\" data-url=\"https://seekingalpha.com/news/3364316-midstates-corrects-sandridge-statement-says-was-inaccurate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364314\" data-ts=\"1529076230\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BG\" target=\"_blank\">BG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364314-bunge-to-delay-ipo-of-brazilian-sugar-milling-unit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bunge to delay IPO of Brazilian sugar milling unit</a></h4><ul>     <li>Bunge (<a href='https://seekingalpha.com/symbol/BG' title='Bunge Limited'>BG</a> <font color='red'>-2.4%</font>) says it is <a href=\"https://www.ft.com/content/6405b26e-70ac-11e8-852d-d8b934ff5ffa\" target=\"_blank\">delaying plans for an IPO</a> of its Brazilian sugar milling business, citing current market conditions.</li>     <li>The price of sugar recently hit a three-year low, weighed down by a bumper Indian harvest, and fell another 1.7% in Chicago at $0.1235/lb. amid a broad drop in commodity prices after China said it would impose retaliatory tariffs following the new U.S. tariffs on $50B of Chinese imports.</li>     <li>Bunge had filed a preliminary prospectus for the sugar business with Brazilian regulators <a href=\"https://seekingalpha.com/news/3356848-bunge-files-brazil-sugar-milling-ipo\" target=\"_blank\">last month</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364314\" data-linked=\"Bunge to delay IPO of Brazilian sugar milling unit\" data-tweet=\"$BG - Bunge to delay IPO of Brazilian sugar milling unit https://seekingalpha.com/news/3364314-bunge-to-delay-ipo-of-brazilian-sugar-milling-unit?source=tweet\" data-url=\"https://seekingalpha.com/news/3364314-bunge-to-delay-ipo-of-brazilian-sugar-milling-unit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364311\" data-ts=\"1529075536\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364311-netflix-to-push-interactive-content\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Netflix to push interactive content</a></h4><ul> <li>A Netflix (<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a> <font color='green'>+0.7%</font>) representative <a href=\"https://thenextweb.com/gaming/2018/06/15/netflix-is-definitely-not-getting-into-gaming-but-define-gaming/\" target=\"_blank\">clarifies</a> to TheNextWeb if <em>Minecraft: Story Mode</em> and other titles on the streaming service are games or content.</li> <li>&ldquo;We don&rsquo;t have any plans to get into gaming. There&rsquo;s a broad spectrum of entertainment available today. Games have become increasingly cinematic, but we view this as interactive narrative storytelling on our service,\" argues the rep.</li> <li>The gaming entry denial could be considered a question of semantics, with users making choices for characters with a controller. It also opens up a whole new category of using existing content and franchises to generate user interest with the \"interactive narrative storytelling\" options.</li> <li>Shares of GameStop (NYSE:<a href='https://seekingalpha.com/symbol/GME' title='GameStop Corp.'>GME</a>) are&nbsp;<font color='green'>up 0.93%</font>&nbsp;after falling back yesterday.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3363707-netflix-clarifies-gaming-plans\" target=\"_blank\">Netflix clarifies gaming plans</a> (June 13)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364311\" data-linked=\"Netflix to push interactive content\" data-tweet=\"$NFLX $NFLX $GME - Netflix to push interactive content https://seekingalpha.com/news/3364311-netflix-to-push-interactive-content?source=tweet\" data-url=\"https://seekingalpha.com/news/3364311-netflix-to-push-interactive-content\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364309\" data-ts=\"1529075415\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/T\" target=\"_blank\">T</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364309-john-malone-isnt-rushing-media-merger-fray\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">John Malone isn&#39;t rushing into media-merger fray</a></h4><ul>   <li>This week's ramp-up in the move toward media content/distribution juggernauts (via AT&amp;T's <a href=\"https://seekingalpha.com/news/3364132-quick-moving-and-t-closes-time-warner-buyout-starting-new-era\" target=\"_blank\">closed deal for Time Warner</a>) isn't yet tempting a titan of the cable industry: John Malone.</li>    <li>Though he owns sizable stakes in Charter (<a href=\"http://seekingalpha.com/symbol/CHTR\" target=\"_blank\">CHTR</a> <font color='red'>-0.2%</font>) and Discovery (<a href=\"http://seekingalpha.com/symbol/DISCA\" target=\"_blank\">DISCA</a> <font color='green'>+3.5%</font>), and despite his reputation as a dealmaking guru, Malone <a href=\"https://www.wsj.com/articles/media-mogul-john-malone-questions-mergers-of-apples-and-oranges-1529017642\" target=\"_blank\">isn't rushing to put them together</a> to keep up with AT&amp;T (NYSE:<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a>) and Comcast (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color='green'>+0.4%</font>).</li>    <li>&ldquo;Why would I put Discovery together with Charter? Apples and oranges,&rdquo; Malone tells Shalini Ramachandran. &ldquo;If you are just forming a conglomerate by putting everything in the same bucket, it eliminates your flexibility, you&rsquo;ve got tax problems, regulatory problems and a lot of problems that these companies operating autonomously don&rsquo;t have.&rdquo;</li>    <li>Charter may pursue smaller content opportunities, like regional sports nets or regional news, or teaming up with distributors in a joint venture to own content.</li>    <li>While he believes both Comcast and AT&amp;T face a challenge pulling financial benefits out of their deals, he says AT&amp;T may have an easier time with its national footprint (vs. the more regional footprints of Comcast and Charter).</li>    <li>Malone has seen regional benefits from a pursuit of Univision (<a href='https://seekingalpha.com/symbol/UVN' title='Univision'>UVN</a>), which has spurned his advances, and he says other smaller content companies are ripe for plucking: Viacom (<a href='https://seekingalpha.com/symbol/VIA' title='Viacom Inc.'>VIA</a> <font color='green'>+1.6%</font>, <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a> <font color='green'>+1.6%</font>), CBS (<a href=\"http://seekingalpha.com/symbol/CBS\" target=\"_blank\">CBS</a> <font color='green'>+1.7%</font>), AMC Networks (<a href=\"http://seekingalpha.com/symbol/AMCX\" target=\"_blank\">AMCX</a> <font color='green'>+0.4%</font>) and Lions Gate (<a href='https://seekingalpha.com/symbol/LGF.A' title='Lions Gate Entertainment Corp.'>LGF.A</a> <font color='green'>+3.8%</font>, <a href='https://seekingalpha.com/symbol/LGF.B' title='Lions Gate Entertainment Corp.'>LGF.B</a> <font color='green'>+2.4%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364309\" data-linked=\"John Malone isn&#39;t rushing into media-merger fray\" data-tweet=\"$T $T $UVN - John Malone isn&#39;t rushing into media-merger fray https://seekingalpha.com/news/3364309-john-malone-isnt-rushing-media-merger-fray?source=tweet\" data-url=\"https://seekingalpha.com/news/3364309-john-malone-isnt-rushing-media-merger-fray\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364308\" data-ts=\"1529075214\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KPTI\" target=\"_blank\">KPTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364308-karyopharms-selinexor-shows-positive-effect-in-multiple-myeloma-study-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Karyopharm&#39;s selinexor shows positive effect in multiple myeloma study; shares up 2%</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17193212-karyopharm-presents-updated-selinexor-phase-1b-2-stomp-myeloma-data-multiple-combinations\" target=\"_blank\">Updated results</a> from a Phase 1b/2 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02343042?titles=stomp&amp;spons=karyopharm&amp;rank=1\" target=\"_blank\">STOMP</a>, evaluating Karyopharm Therapeutics' (<a href='https://seekingalpha.com/symbol/KPTI' title='Karyopharm Therapeutics Inc.'>KPTI</a> <font color='green'>+2.2%</font>) lead drug selinexor + dexamethasone, combined with Velcade (bortezomib), Pomalyst (pomalidomide) or Darzalex (daratumumab), in previously treated patients with multiple myeloma &#40;MM&#41; showed a treatment benefit. The data are being presented at the EHA Annual Meeting in Stockholm.</li><li>The objective response rate &#40;ORR&#41; in the selinexor/dex/bort cohort was 63%.</li><li>The ORR in the selinexor/dex/dara group was 68%.</li><li>The ORR in the selinexor/dex/pom group was 50%.</li><li>Selinexor has Orphan Drug and Fast Track status in the U.S. for this patient population.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364308\" data-linked=\"Karyopharm&#39;s selinexor shows positive effect in multiple myeloma study; shares up 2%\" data-tweet=\"$KPTI - Karyopharm&#39;s selinexor shows positive effect in multiple myeloma study; shares up 2% https://seekingalpha.com/news/3364308-karyopharms-selinexor-shows-positive-effect-in-multiple-myeloma-study-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3364308-karyopharms-selinexor-shows-positive-effect-in-multiple-myeloma-study-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364305\" data-ts=\"1529074966\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RYCEF\" target=\"_blank\">RYCEF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364305-rolls-royce-sees-free-cash-flow-topping-1b-guidance-in-2020\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rolls-Royce sees free cash flow topping £1B guidance in 2020</a></h4><ul>     <li>Rolls-Royce (<a href='https://seekingalpha.com/symbol/RYCEF' title='Rolls Royce Holdings plc'>OTCPK:RYCEF</a>, <a href='https://seekingalpha.com/symbol/RYCEY' title='Rolls Royce Holdings plc ADR'>OTCPK:RYCEY</a>) shoots higher after <a href=\"https://www.marketwatch.com/story/rolls-royce-job-cuts-to-help-hit-1b-in-cash-flow-2018-06-15\" target=\"_blank\">pledging to boost cash flow</a> even as it grapples with the rising costs of fixing its Trent 1000 engines that power Boeing 787 Dreamliners.</li>     <li>Shares <a href=\"https://www.reuters.com/article/us-rolls-royce-hldg-outlook-cfo/rolls-royce-free-cash-flow-could-reach-1-2-billion-pounds-in-2020-idUSKBN1JB1DM\" target=\"_blank\">rose as much as 8%</a> in U.K. trading after Rolls said it would exceed its 2020 guidance for free cash flow of &pound;1B, possibly reaching &pound;1.2B ($1.6B).</li>     <li>&ldquo;The company&rsquo;s new mid-term ambition of more than &pound;1/share in free cash flow implies more than <a href=\"https://www.reuters.com/article/britain-stocks/uk-stocks-eye-strongest-gains-in-a-month-rolls-royce-soars-idUSL8N1TH1LZ\" target=\"_blank\">&pound;1.8B in total free cash flow</a>. This is well ahead of 2020 company compiled consensus,&rdquo; according to Goldman Sachs analysts.</li>     <li>Rolls says belt tightening will allow it to maintain FY 2018 guidance of &pound;350M-&pound;550M million in free cash flow before restructuring costs.</li>     <li>The company said <a href=\"https://seekingalpha.com/news/3363823-rolls-royce-slashes-4600-jobs\" target=\"_blank\">yesterday</a> that it would incur &pound;500M in restructuring costs through 2020 associated with 4,600 job cuts.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364305\" data-linked=\"Rolls-Royce sees free cash flow topping £1B guidance in 2020\" data-tweet=\"$RYCEF $RYCEF $RYCEY - Rolls-Royce sees free cash flow topping £1B guidance in 2020 https://seekingalpha.com/news/3364305-rolls-royce-sees-free-cash-flow-topping-1b-guidance-in-2020?source=tweet\" data-url=\"https://seekingalpha.com/news/3364305-rolls-royce-sees-free-cash-flow-topping-1b-guidance-in-2020\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364303\" data-ts=\"1529074831\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRKR\" target=\"_blank\">MRKR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364303-healthcare-top-5-gainers-losers-of-11-00-06-15-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/15/2018)</a></h4><ul><li><b>Gainers:</b> TPIV <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/NDRA' title='Endra Life Sciences Inc'>NDRA</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/SLNO' title='Soleno Therapeutics, Inc.'>SLNO</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/VSTM' title='Verastem, Inc.'>VSTM</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/ALDR' title='Alder Biopharmaceuticals Inc.'>ALDR</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ACHV' title='Achieve Life Sciences, Inc.'>ACHV</a> <font color='red'>-30%</font>. <a href='https://seekingalpha.com/symbol/CUR' title='Neuralstem, Inc.'>CUR</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/AFMD' title='Affimed Therapeutics'>AFMD</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/GBT' title='Global Blood Therapeutics'>GBT</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/NVIV' title='InVivo Therapeutics Holdings Corp'>NVIV</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364303\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/15/2018)\" data-tweet=\"$MRKR $MRKR $NDRA - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/15/2018) https://seekingalpha.com/news/3364303-healthcare-top-5-gainers-losers-of-11-00-06-15-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3364303-healthcare-top-5-gainers-losers-of-11-00-06-15-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364295\" data-ts=\"1529073447\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FFHL\" target=\"_blank\">FFHL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364295-fuwei-films-up-2_9-posts-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fuwei Films up 2.9% posts Q1 results</a></h4><ul><li>Fuwei Films (<a href='https://seekingalpha.com/symbol/FFHL' title='Fuwei Films &#40;Holdings&#41; Co., Ltd.'>FFHL</a> <font color='green'>+2.9%</font>)&nbsp;<a href=\"https://seekingalpha.com/filing/4067302\" target=\"_blank\">reports Q1</a> revenue growth of 13.2% Y/Y to RMB 76.9M.</li><li>Segment revenue: Stamping and transfer film RMB 30.9M (+14% Y/Y); Printing film RMB 5.9M (-6.3% Y/Y); Metalization film RMB 1.2M (-53.8% Y/Y); Specialty film RMB 33M (+51.4% Y/Y); Base film for other application RMB 6.1M (-40.2% Y/Y).</li><li>Specialty film sales accounted for 42.8% of total revenues, the increase was mainly due to increases in sales volume.</li><li>Gross margin&nbsp;<font color='green'>increased 680 bps</font>&nbsp;to 12.3%.</li><li>Average cost of goods sold increased by 5.1% Y/Y due to the price increase of main raw materials.</li><li>Average product sales prices increased by 13.0% Y/Y, the increase was significantly higher than that in the average cost of goods sold in Q1, which contributed to the increase in gross margin.</li><li>Operating expenses were RMB15.8M (+8% Y/Y), increase was mainly due to the increased allowance for doubtful accounts receivable and increased expense in R&amp;D.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3364046-fuwei-films-reports-q1-results\" target=\"_blank\">Fuwei Films reports Q1 results</a> (June 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3364295\" data-linked=\"Fuwei Films up 2.9% posts Q1 results\" data-tweet=\"$FFHL - Fuwei Films up 2.9% posts Q1 results https://seekingalpha.com/news/3364295-fuwei-films-up-2_9-posts-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3364295-fuwei-films-up-2_9-posts-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364292\" data-ts=\"1529073256\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CUR\" target=\"_blank\">CUR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364292-neuralstem-chief-to-bid-adieu-shares-down-14\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neuralstem chief to bid adieu; shares down 14%</a></h4><ul><li>Thinly traded nano cap Neuralstem (<a href='https://seekingalpha.com/symbol/CUR' title='Neuralstem, Inc.'>CUR</a> <font color='red'>-13.5%</font>) <a href=\"https://www.sec.gov/Archives/edgar/data/1357459/000117184318004654/f8k_061418.htm\" target=\"_blank\">discloses </a>that CEO, CFO &amp; President Richard Daley intends to resign after a transitional period. A search for a successor is underway.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364292\" data-linked=\"Neuralstem chief to bid adieu; shares down 14%\" data-tweet=\"$CUR $SNCA - Neuralstem chief to bid adieu; shares down 14% https://seekingalpha.com/news/3364292-neuralstem-chief-to-bid-adieu-shares-down-14?source=tweet\" data-url=\"https://seekingalpha.com/news/3364292-neuralstem-chief-to-bid-adieu-shares-down-14\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364272\" data-ts=\"1529072669\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HNGR\" target=\"_blank\">HNGR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364272-on-hangers-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Hanger&#39;s Q1 results</a></h4><ul><li>Hanger (<a href='https://seekingalpha.com/symbol/HNGR' title='Hanger, Inc.'>HNGR</a> <font color='green'>+0.1%</font>) reported Q1 revenue of $234M (+0.1% Y/Y), reflecting that Q1 results are generally affected by seasonality, making it the lowest revenue quarter for the year.</li><li>Patient care segment: Revenue $188.71M (+0.46% Y/Y), same clinic revenue per day grew 1.1% and prosthetics revenue grew by 6% Y/Y. Operating margin&nbsp;<font color='green'>improved by 132 bps</font>&nbsp;to 9.1% and Adj. EBITDA margin&nbsp;<font color='green'>improved by 111 bps&nbsp;</font>to 12.2%.</li><li>Product &amp; services segment: Revenue $45.49M (-1.2% Y/Y) due to $1.3M decrease in revenue for therapeutic solution. Operating margin&nbsp;<font color='red'>declined by 26 bps</font>&nbsp;to 12.9% and Adj. EBITDA margin&nbsp;<font color='red'>declined by 51 bps</font>&nbsp;to 19%.</li><li>Q1 Overall margins: Operating&nbsp;<font color='green'>improved by 435 bps</font>&nbsp;to 0.27% and Adj. EBITDA&nbsp;<font color='green'>improved by 80 bps</font>&nbsp;to 6.94%.</li><li>Hanger intends to commence the process of relisting on a national securities exchange during 3Q18. The company plans not to host a conference call regarding first 1Q18 results.</li><li>FY18 outlook: Net revenue and Adj. EBITDA to be consistent with 2017.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3364117-hanger-reports-q1-results\" target=\"_blank\">Hanger reports Q1 results</a> (June 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3364272\" data-linked=\"More on Hanger&#39;s Q1 results\" data-tweet=\"$HNGR - More on Hanger&#39;s Q1 results https://seekingalpha.com/news/3364272-on-hangers-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3364272-on-hangers-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364287\" data-ts=\"1529072618\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATRA\" target=\"_blank\">ATRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364287-atara-bios-tab-cell-shows-durable-effect-in-mid-stage-studies-in-ebv-associated-post\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atara Bio&#39;s tab-cell shows durable effect in mid-stage studies in EBV-associated post-transplant lymphomas; shares up 1%</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17193115-atara-biotherapeutics-tab-cel-achieves-positive-long-term-outcomes-phase-2-studies-patients\" target=\"_blank\">Long-term results</a> from two Phase 2 clinical trials evaluating Atara Biotherapeutics' (<a href='https://seekingalpha.com/symbol/ATRA' title='Atara Biotherapeutics'>ATRA</a> <font color='green'>+0.9%</font>) off-the-shelf T-cell immunotherapy tabelecleucel (tab-cel) in patients with Epstein-Barr virus &#40;EBV&#41;-associated post-transplant lymphoproliferative disorder (EBV+PTLD) showed sustained benefits. The data were presented at the EHA Congress in Stockholm.</li><li>The studies assessed tab-cell in EBV+PTLD patients following hematopoietic cell transplant &#40;HCT&#41; or solid organ transplant &#40;SOT&#41;&nbsp;who failed first-line treatment with Roche's Rituxan (rituximab).</li><li>One- and three-year overall survival &#40;OS&#41; rates were 68% and 55%, respectively, in EBV+PTLD patients following HCT. Median OS was not reached after 23.3 months of follow-up, significantly greater than the expected 16 - 56 days for this patient population.</li><li>In EB+PTLD patients following SOT, one- and three-year OS rates were 64% and 43%, respectively. Median survival was 21.3 months, also superior to the expected survival of a median of 12-13 months.</li><li>Overall response rates in the two groups of patients were 69% and 50%, respectively.</li><li>Two Phase 3 trials are in process.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364287\" data-linked=\"Atara Bio&#39;s tab-cell shows durable effect in mid-stage studies in EBV-associated post-transplant lymphomas; shares up 1%\" data-tweet=\"$ATRA - Atara Bio&#39;s tab-cell shows durable effect in mid-stage studies in EBV-associated post-transplant lymphomas; shares up 1% https://seekingalpha.com/news/3364287-atara-bios-tab-cell-shows-durable-effect-in-mid-stage-studies-in-ebv-associated-post?source=tweet\" data-url=\"https://seekingalpha.com/news/3364287-atara-bios-tab-cell-shows-durable-effect-in-mid-stage-studies-in-ebv-associated-post\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364284\" data-ts=\"1529072360\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAXR\" target=\"_blank\">MAXR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364284-maxar-reaches-settlement-digitalglobe-preferred-holders\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Maxar reaches settlement with DigitalGlobe preferred holders</a></h4><ul>   <li>Maxar Technologies (<a href=\"http://seekingalpha.com/symbol/MAXR\" target=\"_blank\">MAXR</a> <font color='red'>-2.5%</font>) has reached a deal to <a href=\"https://seekingalpha.com/pr/17193244-maxar-settles-appraisal-litigation-former-holders-series-preferred-stock-digitalglobe\" target=\"_blank\">settle all pending litigation</a> with former holders of DigitalGlobe Series A convertible preferred stock.</li>    <li>Those holders of 80,000 preferred DigitalGlobe shares will receive 2,206,464 common shares of Maxar, along with cash for interest accrued on merger consideration from the companies' combination.</li>    <li>\"We are pleased to have reached a resolution with our preferred shareholders,\" Maxar CEO Howard Lance says. \"Our outlook for debt and leverage ratio levels in 2018, as well as cash flows and EPS ... are not impacted by this agreement.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364284\" data-linked=\"Maxar reaches settlement with DigitalGlobe preferred holders\" data-tweet=\"$MAXR - Maxar reaches settlement with DigitalGlobe preferred holders https://seekingalpha.com/news/3364284-maxar-reaches-settlement-digitalglobe-preferred-holders?source=tweet\" data-url=\"https://seekingalpha.com/news/3364284-maxar-reaches-settlement-digitalglobe-preferred-holders\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364274\" data-ts=\"1529071880\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNK\" target=\"_blank\">GNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364274-genco-shipping-trading-prices-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genco Shipping &amp; Trading prices share offering</a></h4><ul> <li>Genco Shipping &amp; Trading (<a href='https://seekingalpha.com/symbol/GNK' title='Genco Shipping & Trading Ltd.'>GNK</a> <font color='red'>-8.6%</font>) prices its 6.1M share offering&nbsp;at a public offering price of $16.50 per share.</li><li>The company says gross proceeds from the offering will be ~$100.7M.</li><li>The offering is expected to close on June 19.</li><li>Genco intends to use the proceeds from the offering for future vessel acquisitions.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17193416-genco-shipping-and-trading-limited-prices-common-stock-offering\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3364274\" data-linked=\"Genco Shipping &amp; Trading prices share offering\" data-tweet=\"$GNK - Genco Shipping &amp; Trading prices share offering https://seekingalpha.com/news/3364274-genco-shipping-trading-prices-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3364274-genco-shipping-trading-prices-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364268\" data-ts=\"1529071545\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLDR\" target=\"_blank\">CLDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364268-clouderaminus-3_7-on-analyst-initiation-23-downside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cloudera -3.7% on analyst initiation at 23% downside</a></h4><ul><li>        Nomura Instinet <a href=\"https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+NomuraInstinet+Starts+Cloudera+%28CLDR%29+at+Reduce/14308625.html\" target=\"_blank\">initiates</a> Cloudera (NYSE:<a href='https://seekingalpha.com/symbol/CLDR' title='Cloudera, Inc.'>CLDR</a>) with a Reduce rating and a $12 price target, a 23% downside to yesterday&rsquo;s close.</li><li>               Cloudera shares are&nbsp;<font color='red'>down 3.7%</font>&nbsp;to $15.03. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3364268\" data-linked=\"Cloudera -3.7% on analyst initiation at 23% downside\" data-tweet=\"$CLDR - Cloudera -3.7% on analyst initiation at 23% downside https://seekingalpha.com/news/3364268-clouderaminus-3_7-on-analyst-initiation-23-downside?source=tweet\" data-url=\"https://seekingalpha.com/news/3364268-clouderaminus-3_7-on-analyst-initiation-23-downside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364267\" data-ts=\"1529071479\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMBO\" target=\"_blank\">AMBO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364267-roller-coaster-ride-for-ambow-education\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roller coaster ride for Ambow Education</a></h4><ul> <li>Ambow Education (<a href='https://seekingalpha.com/symbol/AMBO' title='Ambow Education Holding Ltd.'>AMBO</a> <font color='green'>+25.6%</font>) is extremely volatile this morning, running up as high 51% before some trading halts created a pause. At the peak of the action, Ambow traded as high as $6.10.</li> <li>The Ambow IPO was priced at $4.25 per ADS two weeks ago.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3364267\" data-linked=\"Roller coaster ride for Ambow Education\" data-tweet=\"$AMBO - Roller coaster ride for Ambow Education https://seekingalpha.com/news/3364267-roller-coaster-ride-for-ambow-education?source=tweet\" data-url=\"https://seekingalpha.com/news/3364267-roller-coaster-ride-for-ambow-education\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364249\" data-ts=\"1529069803\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNTR-OLD\" target=\"_blank\">TNTR-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364249-tintri-lacks-liquidity-to-continue-beyond-june-30-tntrminus-39_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tintri lacks liquidity to continue beyond June 30; TNTR -39.5%</a></h4><ul><li>           Tintri (NASDAQ:<a href='https://seekingalpha.com/symbol/TNTR-OLD' title='Tintri, Inc.'>TNTR-OLD</a>) <a href=\"https://seekingalpha.com/pr/17193363-tintri-reports-preliminary-first-quarter-fiscal-2019-financial-results-provides-liquidity\" target=\"_blank\">reports</a> preliminary results for Q1 and says it likely doesn&rsquo;t have sufficient liquidity to continue operations beyond June 30. </li><li> Q1 revenue is expected at around $22M with GAAP loss per share of -$1.14. </li><li> Tintri continues to evaluate strategic options, including a potential sale of the company. </li><li> Tintri shares&nbsp;<font color='red'>plunge 39.5%</font>&nbsp;to $0.44.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3364249\" data-linked=\"Tintri lacks liquidity to continue beyond June 30; TNTR -39.5%\" data-tweet=\"$TNTR-OLD - Tintri lacks liquidity to continue beyond June 30; TNTR -39.5% https://seekingalpha.com/news/3364249-tintri-lacks-liquidity-to-continue-beyond-june-30-tntrminus-39_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3364249-tintri-lacks-liquidity-to-continue-beyond-june-30-tntrminus-39_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364243\" data-ts=\"1529069388\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LYB\" target=\"_blank\">LYB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364243-lyondellbasell-in-talks-braskem-over-potential-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LyondellBasell in talks with Braskem over potential deal</a></h4><ul>     <li>LyondellBasell (NYSE:<a href='https://seekingalpha.com/symbol/LYB' title='LyondellBasell Industries N.V.'>LYB</a>) says it has started talks with Braskem (NYSE:<a href='https://seekingalpha.com/symbol/BAK' title='Braskem S.A.'>BAK</a>) controlling shareholder Odebrecht regarding a \"<a href=\"https://seekingalpha.com/pr/17193297-lyondellbasell-odebrecht-s-enter-exclusive-discussions-concerning-braskem\" target=\"_blank\">potential transaction</a>\" between the companies; BAK <font color='green'>+17.3%</font>, LYB <font color='green'>+3.3%</font> premarket.</li>     <li>\"We believe that the potential combination of LyondellBasell's and Braskem's complementary strengths, product portfolios and operational footprints would create significant value for our shareholders, customers and employees,\" the companies say in a joint statement.</li>     <li>LYB reportedly <a href=\"https://seekingalpha.com/news/3359347-braskem-plus-5-percent-lyondellbasel-reportedly-made-11_4b-offer\" target=\"_blank\">made an offer for BAK in February</a> but talks apparently stalled.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364243\" data-linked=\"LyondellBasell in talks with Braskem over potential deal\" data-tweet=\"$LYB $LYB $BAK - LyondellBasell in talks with Braskem over potential deal https://seekingalpha.com/news/3364243-lyondellbasell-in-talks-braskem-over-potential-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3364243-lyondellbasell-in-talks-braskem-over-potential-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364242\" data-ts=\"1529069069\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLUU\" target=\"_blank\">GLUU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364242-glu-mobileplus-2_4-piper-gives-bullish-initiation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Glu Mobile +2.4% as Piper gives bullish initiation</a></h4><ul>   <li>Glu Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/GLUU' title='Glu Mobile Inc.'>GLUU</a>) is <font color='green'>up 2.4%</font> and tracking toward a three-year high after getting a Street-high price target from Piper Jaffray.</li>    <li>The firm's starting coverage at Overweight, and expects double-digit bookings growth this year and next, along with operating margin expansion to 10%-plus. The company's management is reducing its dependence on new and licensed content, Piper's Michael Olson says.</li>    <li>His $7.50 target implies 20.4% upside from yesterday's close.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364242\" data-linked=\"Glu Mobile +2.4% as Piper gives bullish initiation\" data-tweet=\"$GLUU - Glu Mobile +2.4% as Piper gives bullish initiation https://seekingalpha.com/news/3364242-glu-mobileplus-2_4-piper-gives-bullish-initiation?source=tweet\" data-url=\"https://seekingalpha.com/news/3364242-glu-mobileplus-2_4-piper-gives-bullish-initiation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364240\" data-ts=\"1529068759\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLPS\" target=\"_blank\">CLPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364240-premarket-gainers-of-9-05-06-15-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (06/15/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/CLPS' title='CLPS, Inc'>CLPS</a> <font color='green'>+51%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/GOOS' title='Canada Goose Holdings'>GOOS</a> <font color='green'>+26%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3364162-canada-goose-holdings-beats-0_16\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/BAK' title='Braskem S.A.'>BAK</a> <font color='green'>+18%.</font></li>     <li><a href='https://seekingalpha.com/symbol/VSTM' title='Verastem, Inc.'>VSTM</a> <font color='green'>+9%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3364092-verastem-raise-43m-via-direct-stock-sale-shares-6-percent-hours\" target=\"_blank\">raising</a> $43M via direct stock sale.</li>     <li><a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD'>TXMD</a> <font color='green'>+7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3364218-premarket-analyst-action-healthcare\" target=\"_blank\">positive</a> analyst action.</li>     <li><a href='https://seekingalpha.com/symbol/RDY' title='Dr. Reddy&#39;s Laboratories Limited'>RDY</a> <font color='green'>+6%</font>&nbsp;as FDA approves buprenorphine and naloxone sublingual film in U.S.</li>     <li><a href='https://seekingalpha.com/symbol/CPST' title='Capstone Turbine Corporation'>CPST</a> <font color='green'>+5%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17192179-capstone-continues-pursue-environmental-social-governance-focus-sustainability-footprint\" target=\"_blank\">updating</a>&nbsp;shareholders on its focus on the Environmental, Social, and Governance principals as part of its ongoing effort to improve transparency and corporate responsibility.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364240\" data-linked=\"Premarket Gainers as of 9:05 am (06/15/2018)\" data-tweet=\"$CLPS $CLPS $GOOS - Premarket Gainers as of 9:05 am (06/15/2018) https://seekingalpha.com/news/3364240-premarket-gainers-of-9-05-06-15-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3364240-premarket-gainers-of-9-05-06-15-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364236\" data-ts=\"1529068463\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACHV\" target=\"_blank\">ACHV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364236-premarket-losers-of-9-05-6-15-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (6/15/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/ACHV' title='Achieve Life Sciences, Inc.'>ACHV</a>&nbsp;<font color='red'>-28%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3364183-achieve-life-sciences-continues-selloff-13-percent-premarket\" target=\"_blank\">continued</a> sell off.</li><li><a href='https://seekingalpha.com/symbol/AFMD' title='Affimed Therapeutics'>AFMD</a> <font color='red'>-16%</font>.</li><li><a href='https://seekingalpha.com/symbol/DEST' title='Destination Maternity Corporation'>DEST</a> <font color='red'>-9%</font>.</li><li><a href='https://seekingalpha.com/symbol/XRF' title='China Rapid Finance'>XRF</a>&nbsp;<font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3364182-china-rapid-finance-misses-0_21-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/AI' title='Arlington Asset Investment Corporation'>AI</a> <font color='red'>-8%</font>.</li><li><a href='https://seekingalpha.com/symbol/GNK' title='Genco Shipping & Trading Ltd.'>GNK</a>&nbsp;<font color='red'>-6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3364067-genco-shipping-launches-share-offering\" target=\"_blank\">commencing</a> public offering&nbsp;of common stock.</li><li><a href='https://seekingalpha.com/symbol/FLKS' title='Flex Pharma'>FLKS</a> <font color='red'>-6%</font>.</li><li><a href='https://seekingalpha.com/symbol/LPL' title='LG Display Co., Ltd.'>LPL</a>&nbsp;<font color='red'>-6%</font>&nbsp;after&nbsp;Apple expects to <a href=\"https://seekingalpha.com/news/3364222-wsj-apple-expects-sell-lcd-iphones-oled\" target=\"_blank\">sell</a> more LCD iPhones than OLED.</li><li><a href='https://seekingalpha.com/symbol/CISN' title='Cision Ltd.'>CISN</a> <font color='red'>-6%</font>.</li><li><a href='https://seekingalpha.com/symbol/CRF' title='Cornerstone Total Return Fund'>CRF</a> <font color='red'>-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364236\" data-linked=\"Premarket Losers as of 9:05 am (6/15/2018)\" data-tweet=\"$ACHV $ACHV $AFMD - Premarket Losers as of 9:05 am (6/15/2018) https://seekingalpha.com/news/3364236-premarket-losers-of-9-05-6-15-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3364236-premarket-losers-of-9-05-6-15-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364235\" data-ts=\"1529068439\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADBE\" target=\"_blank\">ADBE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364235-analysts-raise-adobe-systems-targets-after-q2-beats\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts raise Adobe Systems targets after the Q2 beats</a></h4><ul><li>        Analysts raise Adobe (NASDAQ:<a href='https://seekingalpha.com/symbol/ADBE' title='Adobe Systems Incorporated'>ADBE</a>) price targets after the earnings report.</li><li>               Target boosts: BMO Capital Markets, from $260 to $278; Stifel, $250 to $275; Pivotal Research, $199 to $235; JP Morgan, $235 to $260.&nbsp;</li><li>               Source: Briefing.com.&nbsp;</li><li>               Adobe shares are&nbsp;<font color='red'>down 3.3%</font>&nbsp;premarket to $249.51.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3364072-adobe-systems-minus-3-percent-despite-q2-beats-update\" target=\"_blank\">Adobe Systems -3% despite Q2 beats (update)</a> (June 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3364235\" data-linked=\"Analysts raise Adobe Systems targets after the Q2 beats\" data-tweet=\"$ADBE - Analysts raise Adobe Systems targets after the Q2 beats https://seekingalpha.com/news/3364235-analysts-raise-adobe-systems-targets-after-q2-beats?source=tweet\" data-url=\"https://seekingalpha.com/news/3364235-analysts-raise-adobe-systems-targets-after-q2-beats\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364229\" data-ts=\"1529067782\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LPG\" target=\"_blank\">LPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364229-dorian-lpg-rejects-merger-proposal-from-bw\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dorian LPG rejects merger proposal from BW</a></h4><ul>     <li>Dorian LPG (NYSE:<a href='https://seekingalpha.com/symbol/LPG' title='Dorian LPG Ltd.'>LPG</a>) <font color='red'>-6.8%</font> premarket after <a href=\"https://seekingalpha.com/pr/17193353-dorian-lpg-board-declines-bw-lpgs-unsolicited-proposal\" target=\"_blank\">rejecting</a> BW&nbsp;LPG's (<a href='https://seekingalpha.com/symbol/BWLLF' title='BW LPG Ltd.'>OTCPK:BWLLF</a>) unsolicited <a href=\"https://seekingalpha.com/news/3360021-dorian-lpg-gets-merger-offer-bw-lpg\" target=\"_blank\">merger proposal</a>, saying it undervalues the company.</li>     <li>Dorian says BW&nbsp;LPG's offer fails to recognize the value of its younger and more fuel-efficient ships, fails to recognize Dorian's superior commercial performance, forces shareholders to accept equity in a more highly-leveraged combined company, and proposes a dual listing that is unlikely to benefit its shareholders.</li><li><a href=\"https://seekingalpha.com/news/3364158-dorian-lpg-misses-0_06-beats-revenue\" target=\"_blank\">Earlier</a>: Dorian LPG misses by $0.06, beats on revenue (June 15)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364229\" data-linked=\"Dorian LPG rejects merger proposal from BW\" data-tweet=\"$LPG $LPG $BWLLF - Dorian LPG rejects merger proposal from BW https://seekingalpha.com/news/3364229-dorian-lpg-rejects-merger-proposal-from-bw?source=tweet\" data-url=\"https://seekingalpha.com/news/3364229-dorian-lpg-rejects-merger-proposal-from-bw\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364224\" data-ts=\"1529067454\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLUE\" target=\"_blank\">BLUE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364224-bluebirds-lentiglobin-shows-significant-treatment-benefit-in-beta-thalassemia-patients-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bluebird&#39;s LentiGlobin shows significant treatment benefit in beta-thalassemia patients; shares up 1% premarket</a></h4><ul><li>Bluebird bio (NASDAQ:<a href='https://seekingalpha.com/symbol/BLUE' title='bluebird bio, Inc.'>BLUE</a>) is up&nbsp;<font color='green'>1%</font>&nbsp;premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17193151-bluebird-bio-presents-new-data-northstar-hgbminus-204-northstarminus-2-hgbminus-207-studies\" target=\"_blank\">announcement </a>of results from two clinical trials evaluating gene therapy LentiGlobin in patients with transfusion-dependent &beta;-thalassemia &#40;TDT&#41;, an inherited blood disorder characterized by reduced production of hemoglobin. The data were presented the European Hematology Association Congress in Stockholm.</li><li>Results from the completed Phase 1/2 Northstar study showed eight of 10 patients with non-&beta;<sup>0</sup>/&beta;<sup>0</sup>&nbsp;genotypes were transfusion independent for a median of 33 months as of the last follow-up visit.</li><li>Preliminary data from the ongoing Phase 3 Northstar-2 study showed seven of eight patients were maintaining hemoglobin levels of 11.1 - 13.3 g/dL at month 6 (normal range is 13.5 - 17.5 g/dL for men and 12.0 - 15.5 g/dL for women). All seven remained transfusion-free for 4.7 - 15.1 months.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3230525-dosing-underway-bluebirds-late-stage-study-lentiglobin-beta-thalassemia\" target=\"_blank\">Dosing underway in bluebird's late-stage study of LentiGlobin in beta thalassemia</a> (Dec. 14, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3364224\" data-linked=\"Bluebird&#39;s LentiGlobin shows significant treatment benefit in beta-thalassemia patients; shares up 1% premarket\" data-tweet=\"$BLUE - Bluebird&#39;s LentiGlobin shows significant treatment benefit in beta-thalassemia patients; shares up 1% premarket https://seekingalpha.com/news/3364224-bluebirds-lentiglobin-shows-significant-treatment-benefit-in-beta-thalassemia-patients-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3364224-bluebirds-lentiglobin-shows-significant-treatment-benefit-in-beta-thalassemia-patients-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364220\" data-ts=\"1529066141\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STLD\" target=\"_blank\">STLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364220-steel-dynamicsplus-3-after-issuing-above-consensus-q2-earnings-view\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Steel Dynamics +3% after issuing above-consensus Q2 earnings view</a></h4><ul>     <li>Steel Dynamics (NASDAQ:<a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a>)&nbsp;<font color='green'>+3.2%</font> premarket after providing <a href=\"https://seekingalpha.com/pr/17193314-steel-dynamics-provides-second-quarter-2018-earnings-guidance\" target=\"_blank\">Q2 EPS guidance of $1.46-$1.50</a>, ahead of the $1.33 analyst consensus estimate, citing increased steel shipments and metal spread expansion.</li>     <li>The result also would be far higher than prior-year Q2 EPS of&nbsp;$0.63 and Q1 2018 EPS  of&nbsp;$0.96.</li><li>STLD expects Q/Q profitability to come in \"meaningfully higher\" in its steel operations, remain flat in metal recycling and decline in its steel fabrication business.</li><li>Schnitzer Steel (NASDAQ:<a href='https://seekingalpha.com/symbol/SCHN' title='Schnitzer Steel Industries, Inc.'>SCHN</a>)&nbsp;<font color='green'>+1.5%</font> premarket after issuing its own <a href=\"https://seekingalpha.com/news/3364111-schnitzer-steel-sees-q3-earnings-wall-street-consensus\" target=\"_blank\">above-consensus quarterly outlook</a>; Nucor (NYSE:<a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a>) climbed 2.6% in yesterday's trade after <a href=\"https://seekingalpha.com/news/3363916-nucor-guides-q2-earnings-well-wall-street-consensus\" target=\"_blank\">guiding Q2 earnings</a> easily above Wall Street consensus.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364220\" data-linked=\"Steel Dynamics +3% after issuing above-consensus Q2 earnings view\" data-tweet=\"$STLD $STLD $SCHN - Steel Dynamics +3% after issuing above-consensus Q2 earnings view https://seekingalpha.com/news/3364220-steel-dynamicsplus-3-after-issuing-above-consensus-q2-earnings-view?source=tweet\" data-url=\"https://seekingalpha.com/news/3364220-steel-dynamicsplus-3-after-issuing-above-consensus-q2-earnings-view\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364218\" data-ts=\"1529066114\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FPRX\" target=\"_blank\">FPRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364218-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Five Prime Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/FPRX' title='Five Prime Therapeutics, Inc.'>FPRX</a>) initiated with Neutral rating and $19 (8% upside) price target at JPMorgan. Shares up&nbsp;<font color='green'>2%&nbsp;</font>premarket.</li><li>PetMed Express (NASDAQ:<a href='https://seekingalpha.com/symbol/PETS' title='PetMed Express, Inc.'>PETS</a>) initiated with Neutral rating at CL King.</li><li>TherapeuticsMD (NYSEMKT:<a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD'>TXMD</a>) initiated with Overweight rating and $11 (60% upside) price target at JPMorgan. Shares up&nbsp;<font color='green'>4%</font>&nbsp;premarket.</li><li>Charles Rives Labs (NYSE:<a href='https://seekingalpha.com/symbol/CRL' title='Charles River Laboratories International, Inc.'>CRL</a>) upgraded to Overweight at KeyBanc.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364218\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$FPRX $FPRX $PETS - Premarket analyst action - healthcare https://seekingalpha.com/news/3364218-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3364218-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364213\" data-ts=\"1529065728\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VWAGY\" target=\"_blank\">VWAGY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364213-navistar-on-watch-volkswagen-lurks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Navistar on watch as Volkswagen lurks</a></h4><ul> <li>Volkswagen Truck &amp; Bus names M&amp;A specialist Christian Schulz as its new chief financial officer.</li> <li>The hiring by the Volkswagen (VLKAY) subsidiary could increase speculation that a full takeover of Navistar (NYSE:<a href='https://seekingalpha.com/symbol/NAV' title='Navistar International Corporation'>NAV</a>) by the German company is on the way.</li> <li>Shares of Navistar are <font color='green'>up 1.69%</font> premarket to $39.83.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3364213\" data-linked=\"Navistar on watch as Volkswagen lurks\" data-tweet=\"$VWAGY $VWAGY $NAV - Navistar on watch as Volkswagen lurks https://seekingalpha.com/news/3364213-navistar-on-watch-volkswagen-lurks?source=tweet\" data-url=\"https://seekingalpha.com/news/3364213-navistar-on-watch-volkswagen-lurks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364212\" data-ts=\"1529065507\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRRA\" target=\"_blank\">SRRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364212-sierra-oncology-files-for-200m-mixed-shelf-offering-shares-down-3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sierra Oncology files for $200M mixed shelf offering; shares down 3% premarket</a></h4><ul><li>Sierra Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/SRRA' title='Sierra Oncology, Inc.'>SRRA</a>) is down&nbsp;<font color='red'>3%</font>&nbsp;premarket on light volume on the heels of its filing of a <a href=\"https://www.sec.gov/Archives/edgar/data/1290149/000119312518193600/d606301ds3.htm\" target=\"_blank\">prospectus </a>for a $200M mixed shelf offering.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364212\" data-linked=\"Sierra Oncology files for $200M mixed shelf offering; shares down 3% premarket\" data-tweet=\"$SRRA - Sierra Oncology files for $200M mixed shelf offering; shares down 3% premarket https://seekingalpha.com/news/3364212-sierra-oncology-files-for-200m-mixed-shelf-offering-shares-down-3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3364212-sierra-oncology-files-for-200m-mixed-shelf-offering-shares-down-3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364211\" data-ts=\"1529065457\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364211-qualcomm-extends-tender-offer-for-nxp-semiconductors\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qualcomm extends its tender offer for NXP Semiconductors</a></h4><ul><li>        Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>) <a href=\"https://seekingalpha.com/pr/17193235-qualcomm-extends-cash-tender-offer-outstanding-shares-nxp\" target=\"_blank\">extends</a> its cash tender offer to buy NXP Semiconductors (NASDAQ:<a href='https://seekingalpha.com/symbol/NXPI' title='NXP Semiconductors'>NXPI</a>) for $44B.</li><li>               The offer will now expire on June 22.&nbsp;</li><li>               Tendered shares now total about 16.3M or 4.7% of outstanding NXP common shares. &nbsp;&nbsp;</li><li>               Qualcomm shares are&nbsp;<font color='green'>up 0.7%</font>&nbsp;premarket to $59.90.&nbsp;</li><li>               NXP shares are&nbsp;<font color='green'>up 2.6%</font>&nbsp;to $115.96.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3364211\" data-linked=\"Qualcomm extends its tender offer for NXP Semiconductors\" data-tweet=\"$QCOM $QCOM $NXPI - Qualcomm extends its tender offer for NXP Semiconductors https://seekingalpha.com/news/3364211-qualcomm-extends-tender-offer-for-nxp-semiconductors?source=tweet\" data-url=\"https://seekingalpha.com/news/3364211-qualcomm-extends-tender-offer-for-nxp-semiconductors\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364207\" data-ts=\"1529065137\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364207-teva-bails-on-fremanezumab-for-chronic-cluster-headache-in-late-stage-study-shares-down-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teva bails on fremanezumab for chronic cluster headache in late-stage study; shares down 2% premarket</a></h4><ul><li>Teva Pharmaceutical Industries (NYSE:<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a>) is down&nbsp;<font color='red'>2%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/17193270-teva-provides-update-clinical-trial-fremanezumab-use-chronic-cluster-headache\" target=\"_blank\">announcement </a>that it will terminate Phase 3 development of fremenezumab for chronic cluster headache due to lack of efficacy.</li><li>Phase 3 development in patients with episodic cluster headache will continue as planned.</li><li>The company's marketing applications in the U.S. and Europe seeking approval for fremanezumab for the prevention of migraine in adults are currently under review.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364207\" data-linked=\"Teva bails on fremanezumab for chronic cluster headache in late-stage study; shares down 2% premarket\" data-tweet=\"$TEVA - Teva bails on fremanezumab for chronic cluster headache in late-stage study; shares down 2% premarket https://seekingalpha.com/news/3364207-teva-bails-on-fremanezumab-for-chronic-cluster-headache-in-late-stage-study-shares-down-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3364207-teva-bails-on-fremanezumab-for-chronic-cluster-headache-in-late-stage-study-shares-down-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364203\" data-ts=\"1529064511\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPLK\" target=\"_blank\">SPLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364203-splunkminus-3_8-citi-moves-to-sell\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Splunk -3.8% as Citi moves to Sell</a></h4><ul><li>        Citigroup downgrades Splunk (NASDAQ:<a href='https://seekingalpha.com/symbol/SPLK' title='Splunk Inc.'>SPLK</a>) from Neutral to Sell</li><li>        Source: Briefing.com.</li><li>           Splunk shares are&nbsp;<font color='red'>down 3.8%</font>&nbsp;premarket to $115.&nbsp;                    </li></ul><div class=\"tiny-share-widget\" data-id=\"3364203\" data-linked=\"Splunk -3.8% as Citi moves to Sell\" data-tweet=\"$SPLK - Splunk -3.8% as Citi moves to Sell https://seekingalpha.com/news/3364203-splunkminus-3_8-citi-moves-to-sell?source=tweet\" data-url=\"https://seekingalpha.com/news/3364203-splunkminus-3_8-citi-moves-to-sell\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364188\" data-ts=\"1529064081\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBT\" target=\"_blank\">GBT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364188-gbts-voxelotor-shows-lower-treatment-effect-in-adolescents-scd-in-mid-stage-study-shares-slip\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GBT&#39;s voxelotor shows lower treatment effect in adolescents with SCD in mid-stage study; shares slip 4% premarket</a></h4><ul><li>Global Blood Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GBT' title='Global Blood Therapeutics'>GBT</a>) <a href=\"https://seekingalpha.com/pr/17193117-gbt-announces-new-phase-2a-voxelotor-data-adolescents-sickle-cell-disease-scd-23rd-european\" target=\"_blank\">announces</a> data from patients treated with the 900 mg dose of voxelotor in the ongoing HOPE-KIDS 1 Study, a Phase 2a open-label study in adolescents with sickle cell disease &#40;SCD&#41; at the European Hematology Association &#40;EHA&#41; Congress in&nbsp;Stockholm.</li>       <li>The EHA presentation analyzed 22 patients who received voxelotor 900 mg/day for 24 weeks in Part B. Data showed the following results achieved with voxelotor treatment:</li><li>Results demonstrated sustained and durable improvements in hemoglobin levels and a reduction in clinical measures of hemolysis with voxelotor.</li><li>43% (55% rate reported in December 2017) of patients achieved a hemoglobin response &gt;1 g/dL at 24 weeks with a median hemoglobin change from baseline of 0.7 g/dL.</li><li>Total symptom scores improved in 13 of 21 patients.</li><li>55% of patients had a numerical decrease in transcranial doppler &#40;TCD&#41; flow; among hemoglobin responders (&gt;1 g/dL), 88% had a numerical decrease in TCD at 24 weeks.</li>          <li>Voxelotor (GBT440) is being developed as an oral, once-daily therapy for patients with SCD. Voxelotor works by increasing hemoglobin's affinity for oxygen.</li><li>Shares are down&nbsp;<font color='red'>4%</font>&nbsp;premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3317444-global-bloods-voxelotor-shows-positive-action-mid-stage-study-adolescents-sickle-cell-disease\" target=\"_blank\">Global Blood's voxelotor shows positive action in mid-stage study in adolescents with sickle cell disease, two deaths in compassionate use study pressures shares, down 10%</a> (Dec. 11, 2017)</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3364188\" data-linked=\"GBT&#39;s voxelotor shows lower treatment effect in adolescents with SCD in mid-stage study; shares slip 4% premarket\" data-tweet=\"$GBT - GBT&#39;s voxelotor shows lower treatment effect in adolescents with SCD in mid-stage study; shares slip 4% premarket https://seekingalpha.com/news/3364188-gbts-voxelotor-shows-lower-treatment-effect-in-adolescents-scd-in-mid-stage-study-shares-slip?source=tweet\" data-url=\"https://seekingalpha.com/news/3364188-gbts-voxelotor-shows-lower-treatment-effect-in-adolescents-scd-in-mid-stage-study-shares-slip\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>39&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364183\" data-ts=\"1529062367\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACHV\" target=\"_blank\">ACHV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364183-achieve-life-sciences-continues-selloff-down-13-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Achieve Life Sciences continues selloff, down 13% premarket</a></h4><ul><li>Thinly traded nano cap Achieve Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/ACHV' title='Achieve Life Sciences, Inc.'>ACHV</a>) is down&nbsp;<font color='red'>13%</font>&nbsp;premarket on light volume. Shares have sold off almost&nbsp;<font color='red'>65%</font>&nbsp;since touching $14.60 on May 7.</li><li>On May 9, it <a href=\"https://seekingalpha.com/pr/17158667-achieve-reports-financial-results-first-quarter-2018\" target=\"_blank\">reported </a>a 58% biochemical abstinence rate from a Phase 1/2 study of cytisine in healthy volunteer smokers. A Phase 3 trial is next up.</li><li>At the end of March, the company had $4.4M in quick assets. Operations consumed $2.2M in Q1.</li><li>It is preparing an <a href=\"https://www.sec.gov/Archives/edgar/data/949858/000156459018015552/achv-S1A.htm\" target=\"_blank\">equity offering</a> of Class A and Class B Units.</li><li><strong>Update</strong>: The company has <a href=\"https://seekingalpha.com/pr/17193341-achieve-life-sciences-announces-pricing-12-million-underwritten-public-offering\" target=\"_blank\">priced </a>the Class A units, each consisting of one common share and one five-year warrant to purchase one common share, at $4.00. Each Class B unit, consisting of one share of Series A preferred stock and one five-year warrant to purchase 250 common shares, is priced at $1,000.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364183\" data-linked=\"Achieve Life Sciences continues selloff, down 13% premarket\" data-tweet=\"$ACHV - Achieve Life Sciences continues selloff, down 13% premarket https://seekingalpha.com/news/3364183-achieve-life-sciences-continues-selloff-down-13-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3364183-achieve-life-sciences-continues-selloff-down-13-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364178\" data-ts=\"1529061834\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364178-cowen-raises-amd-target-to-29-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cowen raises its AMD target to 29% upside</a></h4><ul><li>        Cowen <a href=\"https://www.streetinsider.com/Analyst+PT+Change/AMD+%28AMD%29+PT+Raised+to+%2421+at+Cowen/14310185.html\" target=\"_blank\">raises</a> its AMD (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) price target from $18 to $21, a 29% upside to yesterday&rsquo;s close.</li><li>               Rating maintained at Outperform.&nbsp;</li><li>               AMD shares are&nbsp;<font color='green'>up 0.8%</font>&nbsp;premarket to $16.38. &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3364178\" data-linked=\"Cowen raises its AMD target to 29% upside\" data-tweet=\"$AMD - Cowen raises its AMD target to 29% upside https://seekingalpha.com/news/3364178-cowen-raises-amd-target-to-29-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3364178-cowen-raises-amd-target-to-29-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>167&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364177\" data-ts=\"1529061695\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOS\" target=\"_blank\">GOOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364177-canada-gooseplus-16-after-posting-unexpected-profit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canada Goose +16% after posting unexpected profit</a></h4><ul> <li>Canada Goose (NYSE:<a href='https://seekingalpha.com/symbol/GOOS' title='Canada Goose Holdings'>GOOS</a>) reports an unexpected profit in FQ4.</li>  <li>The company generated adjusted EBITDA of C$21.7M during the quarter vs. C$6.01M consensus estimate. Adjusted EBITDA margin increased by 517 basis points to 25.2%.</li> <li>For the full fiscal year, direct-to-consumer revenue rose 121% to $255M as e-commerce and the new stores in New York City and Toronto contributed.</li><li>CEO update: \"Our execution in fiscal 2018 was exceptional across all growth strategies and key metrics. These results reinforce my belief that we are still just scratching the surface of our global potential. As we continue to bring more Canada Goose to more of the world, we are resolutely focused on the long term and what we need to get there.\"</li> <li>FY19 guidance expectations: Annual revenue growth of at least 20%, adjusted EBITDA margin expansion of at least 50 basis points, annual growth in adjusted net income per diluted share of at least 25%.</li> <li>Shares of Canada Goose are <font color='green'>up 15.58%</font> in premarket trading to $52.99.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3364162-canada-goose-holdings-beats-0_16\" target=\"_blank\">Canada Goose Holdings beats by $0.16</a> (June 15)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364177\" data-linked=\"Canada Goose +16% after posting unexpected profit\" data-tweet=\"$GOOS - Canada Goose +16% after posting unexpected profit https://seekingalpha.com/news/3364177-canada-gooseplus-16-after-posting-unexpected-profit?source=tweet\" data-url=\"https://seekingalpha.com/news/3364177-canada-gooseplus-16-after-posting-unexpected-profit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364175\" data-ts=\"1529061326\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMAG\" target=\"_blank\">AMAG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364175-amag-to-divest-cord-blood-registry-for-530m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMAG to divest Cord Blood Registry for $530M</a></h4><ul><li>AMAG Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AMAG' title='AMAG Pharmaceuticals, Inc.'>AMAG</a>) has <a href=\"https://seekingalpha.com/pr/17193217-amag-pharmaceuticals-announces-divestiture-cord-blood-registry\" target=\"_blank\">agreed to sell</a> its Cord Blood Registry unit to private equity shop GI Partners for $530M in cash. Most of the proceeds will be used to pay off the remaining $475M of its 7.875% Senior Notes due 2023.</li><li>The transaction should close next quarter. Management will update guidance afterward.</li><li>Shares will resume trading at 7:30 am ET.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364175\" data-linked=\"AMAG to divest Cord Blood Registry for $530M\" data-tweet=\"$AMAG - AMAG to divest Cord Blood Registry for $530M https://seekingalpha.com/news/3364175-amag-to-divest-cord-blood-registry-for-530m?source=tweet\" data-url=\"https://seekingalpha.com/news/3364175-amag-to-divest-cord-blood-registry-for-530m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364164\" data-ts=\"1529060064\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDY\" target=\"_blank\">RDY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364164-fda-approves-dr-reddys-buprenorphine-and-naloxone-sublingual-film-in-u-s-shares-ahead-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA approves Dr. Reddy&#39;s buprenorphine and naloxone sublingual film in U.S. ; shares ahead 5% premarket</a></h4><ul> <li>Dr. Reddy&rsquo;s Laboratories (NYSE:<a href='https://seekingalpha.com/symbol/RDY' title='Dr. Reddy&#39;s Laboratories Limited'>RDY</a>) has <a href=\"https://seekingalpha.com/pr/17193087-dr-reddys-laboratories-announces-usfda-final-approval-launch-buprenorphine-naloxone\" target=\"_blank\">received</a> final approval from the FDA and is launching Buprenorphine and       Naloxone Sublingual Film, 2 mg/0.5 mg, 4 mg/1 mg, 8 mg/2 mg, and 12 mg/3       mg, a therapeutic equivalent generic version of Suboxone&nbsp;(buprenorphine and naloxone) sublingual film, in the U.S.</li>     <li>Buprenorphine and naloxone are used to treat adults with opioid       dependence/addiction. The combination is used as       part of a complete treatment program including prescription monitoring,       counseling, and behavioral therapy.</li><li>Shares are up&nbsp;<font color='green'>5%</font>&nbsp;premarket.</li>                         </ul><div class=\"tiny-share-widget\" data-id=\"3364164\" data-linked=\"FDA approves Dr. Reddy&#39;s buprenorphine and naloxone sublingual film in U.S. ; shares ahead 5% premarket\" data-tweet=\"$RDY - FDA approves Dr. Reddy&#39;s buprenorphine and naloxone sublingual film in U.S. ; shares ahead 5% premarket https://seekingalpha.com/news/3364164-fda-approves-dr-reddys-buprenorphine-and-naloxone-sublingual-film-in-u-s-shares-ahead-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3364164-fda-approves-dr-reddys-buprenorphine-and-naloxone-sublingual-film-in-u-s-shares-ahead-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li>","count":64,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}